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Abstract
Background: Carnation Italian ringspot virus (CIRV) is a positive-strand RNA virus that causes
massive structural alterations of mitochondria in infected host cells, the most conspicuous being
the formation of numerous internal vesicles/spherules that are derived from the mitochondrial
outer membrane and serve as the sites for viral RNA replication. While the membrane-bound
components of the CIRV replication complex, including a 36-kD RNA-binding protein (p36), are
known to be essential for these changes in mitochondrial morphology and are relatively well
characterized in terms of their roles in nascent viral RNA synthesis, how these proteins are
specifically targeted and inserted into mitochondria is poorly defined.
Results: Here we report on the molecular signal responsible for sorting p36 to the mitochondrial
outer membrane. Using a combination of gain-of-function assays with portions of p36 fused to
reporter proteins and domain-swapping assays with p36 and another closely-related viral RNA-
binding protein, p33, that sorts specifically to the peroxisomal boundary membrane, we show that
the mitochondrial targeting information in p36 resides within its two transmembrane domains
(TMDs) and intervening hydrophilic loop sequence. Comprehensive mutational analysis of these
regions in p36 revealed that the primary targeting determinants are the moderate hydrophobicity
of both TMDs and the positively-charged face of an amphipathic helix within the intervening loop
sequence. We show also using bimolecular fluorescence complementation (BiFC) that p36
interacts with certain components of the translocase complex in the mitochondrial outer
membrane (TOM), but not with the sorting and assembly machinery (SAM).
Conclusion: Our results provide insight to how viruses, such as CIRV, exploit specific host-cell
protein sorting pathways to facilitate their replication. The characterization of the targeting and
insertion of p36 into the mitochondrial outer membrane also sheds light on the mechanisms
involved in sorting of host-cell membrane proteins to mitochondria, a process that has been largely
unexplored in plants.
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The hallmark of positive-strand RNA viruses is their abil-
ity to recruit distinct host-cell organelle membranes in
order to create unique compartments at which viral RNA
replication takes place [1-3]. This process is exemplified
during tombusvirus infections of plant cells where,
depending on the virus and host, peroxisomes or mito-
chondria undergo a series of remarkable structural rear-
rangements that ultimately results in their transformation
into so-called multivesicular bodies (MVBs) [reviewed in
[4,5]]. These novel structures form initially by the prolif-
eration and progressive invagination of the organelle's
boundary (outer) membrane, resulting in the matrix or
intermembrane space containing hundreds of small
(~80–150 nm diameter) vesicles and/or spherules which
serve as the sites of viral RNA replication. MVBs often then
form one or more large, vesicle/spherule-containing
appendages that encircle portions of the neighbouring
cytosol, yielding C-shaped or doughnut-shaped structures
that frequently coalesce with other MVBs in the infected
cell.
While the cytolopathological features of MVB biogenesis
have been relatively well studied, many fundamental
questions remain about the molecular mechanisms
underlying the interaction of viral replication factors with
host-cell membranes. For instance, the significance of the
diversity of intracellular membranes used by different
viruses is unknown. Likewise, the events involved in the
specific intracellular targeting and membrane integration/
assembly of the viral replication proteins, as well as the
host-cell factors that facilitate these processes and/or
mediate membrane remodelling are, in most cases, poorly
studied and unclear.
CIRV is a member of the Tombusviridae family of positive-
strand RNA plant viruses that include Cymbidium ringspot
virus (CymRSV) and the Tomato bushy stunt virus (TBSV)
[6,7]. Similar to other tombusviruses, the CIRV genome
consists of a 4.8-kb linear, monopartite RNA molecule
that contains five open reading frames (ORFs) [8], includ-
ing ORF1 and ORF2, a 36-kD RNA-binding protein (p36)
and its translation read-through product, a 95-kD RNA-
dependent RNA polymerase (p95). Both p36 and p95 are
the integral membrane-bound components of the virus'
RNA replication complex and are located within the virus-
induced vesicles/spherules of the MVB [9-12]. The
remaining three ORFs in the CIRV genome encode a 41-
kD coat protein, a 22-kD protein required for cell-to-cell
movement of the virus, and a 19-kD protein that func-
tions as a suppressor of virus-induced gene silencing [7].
In CIRV-infected cells, MVBs are derived from mitochon-
dria [13] and the principal viral component involved in
this process appears to be p36. For instance, analysis of
full-length hybrid infectious clones of CIRV and CymRSV,
which, unlike CIRV, recruits peroxisomes for its viral RNA
replication, revealed that both of their ORF1s, namely p36
and the CymRSV 33-kD membrane-bound replication
protein (p33), contain the determinants for the formation
of MVBs derived from mitochondria or peroxisomes,
respectively [14,15]. p36 expressed alone in either
tobacco mesophyll or in yeast (Saccharomyces cerevisiae)
cells is also sufficient to target the green fluorescent pro-
tein (GFP) to mitochondria and while these organelles are
not entirely transformed into MVBs, they displayed dra-
matic alterations in their distribution and morphology,
including proliferation of their outer membranes [16,17].
Interestingly, results from previous studies of p36 suggest
also that its sorting to mitochondrial outer membranes is
atypical since it does not appear to rely on mitochondrial-
surface proteinaceous receptors nor a targeting/insertion
signal similar to those typically found in most host-cell
mitochondrial membrane- or matrix-localized proteins
[18]. The nature of the sorting pathway for p36, instead, is
considered to be complex, consisting of multiple, perhaps
novel, targeting/insertion signals and a unique membrane
insertion mechanism [18], however, this premise has not
been experimentally tested.
Here, we describe the results of a comprehensive study of
the molecular signals involved in the mitochondrial tar-
geting of p36. We show using a combination of p36-
reporter fusion proteins and p36-p33 hybrid proteins,
wherein specific regions of p36 were replaced with those
that constitute the peroxisomal targeting information in
p33 (and vice versa), that the mitochondrial sorting of
p36 is mediated by an internal targeting signal consisting
of its two moderately hydrophobic TMDs and a posi-
tively-charged face of an amphipathic helix located within
the intervening loop sequence. Notably, this targeting sig-
nal in p36 resembles the targeting determinants in several
authentic mitochondrial outer membrane proteins from
evolutionarily diverse organisms. We show also that p36
interacts with certain components of the translocase in the
mitochondrial outer membrane (TOM), but not with the
sorting and assembly machinery (SAM), in a manner con-
sistent with the insertion of some host-cell mitochondrial
outer membrane proteins. The implications of these find-
ings in terms of CIRV's and other positive-strand RNA
viruses' strategies to appropriate and subsequently modify
mitochondrial sorting pathways to their own advantage
are briefly discussed. Also discussed is how these results
provide insight to the cellular processes underlying plant
mitochondrial outer membrane protein sorting in gen-
eral.Page 2 of 26
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p36 expressed transiently in tobacco BY-2 cells is localized 
to mitochondrial outer membranes
To begin to decipher the intracellular targeting informa-
tion within p36, we took advantage of tobacco (Nicotiana
tabacum) Bright Yellow-2 (BY-2) suspension-cultured cells
as a well-characterized in vivo import system [19-21]. Spe-
cifically, BY-2 cells were transiently transformed (via biol-
istic bombardment) with plasmid DNA encoding p36
fused at either its N or C terminus to the myc-epitope rec-
ognition motif (-EQKLISEEDL-; [22]) and, then, follow-
ing a 4 h incubation period to allow for gene expression
and protein sorting, cells were processed for indirect
immunofluorescence confocal-laser scanning microscopy
(CLSM). As shown in Figure 1, both transiently-expressed
myc-p36 and p36-myc localized exclusively to globular
structures that were found mostly within the perinuclear
region of the cell and contained endogenous E1β, a pro-
tein subunit of the pyruvate dehydrogenase complex
located in the mitochondrial matrix [23]. Interestingly,
close inspection of these p36-containing globular struc-
tures at higher magnification revealed that they actually
consisted of numerous torus or donut-shaped structures
that contained myc-p36 or p36-myc and that enclosed
spherical fluorescent structures containing matrix-local-
ized E1β (refer to arrowheads in Figure 1). These toroidal
structures also contained the endogenous mitochondrial
outer membrane protein porin [24], as evidenced by the
colocalization of p36-myc and porin (Figure 1). Taken
together, these results indicate that p36 sorts to mitochon-
drial outer membranes in BY-2 cells and that the expres-
sion of this viral protein causes mitochondria to coalesce
in perinuclear regions, in contrast to mitochondria in
non-transformed cells that are distributed throughout the
Localization of p36 to the outer mitochondrial membrane in BY-2 cellsFigure 1
Localization of p36 to the outer mitochondrial membrane in BY-2 cells. Tobacco BY-2 cells were either non-transformed or transformed tran-
siently (via biolistic bombardment) with either myc-p36 or p36-myc and then processed for immunofluorescence CLSM. Hatched boxes represent the 
portion of the cells shown at higher magnification in the panels to the right. Arrowheads indicate obvious examples of the torus fluorescent structures 
containing myc-p36 or p36-myc either delineating the spherical structures containing endogenous mitochondrial matrix-localized E1β or colocalizing with 
the torus structures containing the endogenous mitochondrial outer membrane protein porin. The bottom row of images show representative immun-
ofluorescence staining patterns attributable to endogenous porin and E1β in non-transformed cells; arrowheads in the high magnified images indicate obvi-
ous examples of porin-containing torus structures (similar to those containing myc-p36 or p36-myc [compare with cells above]) enclosing the E1β-
containing spheres. Bar = 10 μm.Page 3 of 26
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enous mitochondrial porin and E1β in the non-trans-
formed cells shown in the bottom row of Figure 1.
While it remains to be determined whether the aggregated
mitochondria in p36-transformed cells were modified
also in terms of their ultrastructure, this possibility is
likely since expression of p36 (e.g., p36-GFP) in various
other cell types (e.g., leaf mesophyll protoplasts and yeast
cells) led to similar aggregations of mitochondria, as well
as a proliferation of their outer membranes [16-18].
Indeed, high-magnified views of myc-p36- or p36-myc-
transformed BY-2 cells in this study revealed that the
immunostaining pattern attributable to endogenous
porin in these cells was more diffuse than that observed in
non-transformed cells (Figure 1), suggesting that the outer
mitochondrial membranes in the former cells were altered
in terms of their morphology. The nature of these changes
or the mechanism(s) by which p36 participates in this
process were not, however, examined further.
The localization of myc-p36 and p36-myc to mitochon-
dria indicates also that appending the myc epitope to the
N or C terminus of p36 did not disrupt the protein's nor-
mal targeting behaviour, since non-tagged (wild-type)
p36 colocalized also with endogenous porin in the outer
membranes of aggregated mitochondria (refer to Addi-
tional file 1A, top row). p36 was immunodetected in these
cells using polyclonal antibodies raised against a synthetic
peptide corresponding to an amino acid sequence in the
C-terminal half of TBSV p33 and p92 replicase proteins
(residues 184–203; [25]) and conserved in CIRV p36 and
p95 (residues 218–237). However, due to limited availa-
bility of this antibody reagent, only myc-tagged versions
of p36, primarily p36-myc, were employed in the remain-
der of the experiments described in this manuscript.
The localization of epitope-tagged and wild-type p36 to
mitochondrial outer membranes, and their subsequent
effects on mitochondrial morphology and distribution,
were similar also to when p36 was co-expressed with its
allied replication protein, p95, either together alone (Rep)
or together in the context of full-length CIRV, i.e., a CIRV
cDNA positioned within a plant expression plasmid
(Additional file 1A). Confirmation of the infectivity of
this CIRV cDNA was that Chenopodium quinoa leaves 7 to
10 days after rub-inoculation displayed local lesions
(Additional file 1B) that resembled the disease symptoms
reported for leaves infected with native CIRV RNA [4].
Moreover, electron microscopic analyses of these CIRV
cDNA-inoculated leaf samples revealed the presence of
mitochondrial-derived MVBs that were not observed in
cells from mock-transformed leaves (Additional file 1C).
The results for the mitochondrial localization of p36
expressed in the context of full-length CIRV (or Rep) are
important because they indicate that, compared to the
expression of p36 alone (either wild-type or epitope
tagged), the viral protein behaves in a similar manner in
terms of its intracellular localization. Thus, we deemed it
appropriate to study the mitochondrial targeting informa-
tion of p36 when expressed on its own.
p36 is orientated in mitochondrial outer membranes in an 
Nout-Cout topology
The topological orientation of p36 in mitochondrial outer
membranes was assessed using a differential detergent
permeabilization assay [26]. Specifically, BY-2 cells were
transformed transiently with N- or C-terminal myc-tagged
versions of p36 and then fixed and incubated either with
triton X-100, which perforates all cellular membranes, or
with digitonin, which perforates only the plasma mem-
brane.
As shown in Figure 2 (top row), control experiments with
myc-p36-transformed cells verified that permeabilization
with triton X-100 allowed for the immunodetection (via
Topological orientation of p36 in differentially permeabilized BY-2 cellsFigure 2
Topological orientation of p36 in differentially permeabilized 
BY-2 cells. BY-2 cells were either non-transformed or transformed tran-
siently (via biolistic bombardment) with myc-p36 or p36-myc, fixed, and 
then permeabilized with either triton X-100 (which permeabilizes both the 
plasma membrane and organellar membranes) or digitonin (which permea-
bilizes only the plasma membrane). Permeabilized cells were then proc-
essed for (immuno)epifluorescence microscopy using antibodies raised 
against (as indicated by the labelling at the top left of each micrograph) 
either cytosolic α-tubulin, mitochondrial matrix-localized E1β, the myc 
epitope and/or the p36 C-terminal peptide sequence (amino acids 218–
237) located downstream of the protein's second (of two) predicted 
TMDs. Bar = 10 μm.Page 4 of 26
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within the cytosol (i.e., α-tubulin) and within subcellular
compartments (i.e., E1β within the mitochondrial
matrix), whereas permeabilization with digitonin allowed
for the immunodetection of only cytosolic proteins (i.e.,
α-tubulin, but not E1β). Figure 2 shows also that when
myc-p36- or p36-myc-transformed cells were permeabi-
lized with either triton X-100 or digitonin both expressed
proteins were immunodetected, whereas endogenous E1β
was only immunodetected in the corresponding triton-X-
100-permeabilized cells. Likewise, myc-p36 was immun-
odetected in both triton X-100- and digitonin-permeabi-
lized cells that were incubated with antibodies specific for
myc or the p36 C-terminal peptide mentioned above, i.e.,
amino acid residues 218–237 located downstream of the
second (of two) predicted TMDs in p36.
Overall, these data are in agreement with the previously
proposed model for the membrane topology of p36 based
on the hydropathy profile of the protein's primary amino
acid sequence [15] and protease resistance analyses of p36
in either CIRV-infected plants or isolated mitochondria
[18]. In this model, p36 is predicted to be an integral
membrane protein that contains two TMDs (residues
102–119 and 166–188), an intervening loop region (res-
idues 120–165) orientated towards the mitochondrial
intermembrane space, and N- and C terminal portions of
the protein (residues 1–101 and 189–296) that face the
cytosol. Unfortunately, our efforts to confirm the inward
orientation of the intervening loop sequence in p36 were
unsuccessful, because addition of the myc-epitope
sequence to this portion of the protein caused the result-
ing mutant to be mislocalized from mitochondria to the
cytosol in transformed cells (data not shown), a result that
is likely due to the fact that, as discussed below, the loop
sequence of p36 contains essential mitochondrial target-
ing information that was disrupted by the addition of the
myc-epitope motif.
An internal domain of p36 composed of two TMDs and an 
intervening loop sequence functions as a mitochondrial 
targeting signal
While previous studies using chimeras of CIRV p36 and
CymRSV p33, expressed either in the context of the full-
length virus or alone, revealed that the N terminal half of
each protein is responsible for its sorting to mitochondria
and peroxisomes, respectively [14,15], results from subse-
quent mutational analyses of p36 expressed alone pro-
vided only limited insight to the precise nature the
protein's mitochondrial targeting information [18]. For
instance, based on the targeting results of various p36
deletion mutants, Weber-Lotfi et al. [18] concluded that
the mitochondrial sorting of p36 is mediated by multiple
determinants located within a relatively large portion of
the protein's N-terminal half, i.e., residues 84–196 which
includes both of the protein's TMDs and their flanking
regions, and that together these determinants might func-
tion cooperatively as a so-called signal loop-anchor type
mitochondrial targeting sequence. These authors also
speculated that this putative signal loop-anchor targeting
sequence for p36 was unique because, rather than being
comprised of non-continuous structural elements and/or
three-dimensional folding features, such as those that typ-
ically constitute the targeting determinants in host-cell
multi-spanning mitochondrial outer membrane proteins
with β-barrel structures, the mitochondrial targeting
determinants in p36 (a non-β-barrel protein) were part of
a linear stretch of the protein. The physicochemical prop-
erties of these potentially novel targeting determinants in
p36 were not, however, defined. Thus, to better under-
stand the mitochondrial targeting information in p36 we
carried out a comprehensive mutational analysis of the
protein, employing initially both gain-of-function target-
ing assays with different portions of p36 fused to a
reporter protein (Figure 3) and domain-swapping assays
with p36 and p33 (Figure 4).
As shown in Figure 3A, gain-of-function targeting experi-
ments were carried out using a series of fusion proteins
that consisted of p36, or portions thereof, appended to
the bacterial passenger protein chloramphenicol acetyl-
transferase (CAT) and that were expressed transiently in
BY-2 cells. The representative micrographs presented in
Figure 3B show that while CAT expressed alone accumu-
lated throughout the cytosol, p36-CAT, consisting of full-
length p36 fused to the N terminus of CAT, localized
exclusively to aggregated mitochondria. These latter data
are consistent with the localization of myc-tagged and
wild-type p36 to (aggregated) mitochondria in BY-2 cells
(refer to Figure 1 and Additional file 1), as well as p36
fused to GFP and expressed transiently (via agrobacterium
infiltration) in tobacco leaf mesophyll cells [17,18], and
indicate that the CAT moiety used here as a reporter pas-
senger protein does not alter the sorting behaviour of p36.
Similar to p36-CAT, p36 1-190-CAT, containing residues
1–190 of p36 including the protein's N-terminal
hydrophilic domain, TMDs 1 and 2, and the intervening
loop sequence appended to CAT, localized to (aggre-
gated) mitochondria (Figure 3B), confirming also the
results presented previously by Weber-Lotfi et al. [18] that
the N-terminal half of the protein contains its mitochon-
drial targeting information. By contrast, p36 1-120-CAT,
which includes only the N-terminal hydrophilic domain
and TMD1 of p36, accumulated in the cytosol. Notably,
the mitochondria in these p36 1-120-CAT-transformed
cells, similar to mitochondria in cells transformed with
CAT alone, were not altered in terms of their morphology
and/or distribution (compare endogenous E1β immunos-
taining in p36 1-120-CAT-and CAT-transformed cells; Fig-Page 5 of 26
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protein was not targeted to mitochondria.
Other p36-CAT fusion proteins comprised of smaller por-
tions of the p36 N-terminal half also did not target to
mitochondria. That is, both p36 90-164-CAT and p36
120-164-CAT, consisting of TMD1 and the intervening
loop sequence and the intervening loop sequence alone,
respectively, localized to the cytosol (Figure 3B). On the
other hand, both p36 120-190-CAT and p36 90-190-CAT
localized to (aggregated) mitochondria, albeit the former
fusion protein only did so in a relatively inefficient man-
ner since it accumulated also in the cytosol (Figure 3B).
Based on the results presented here (Figure 3), p36 90-
190-CAT contains the minimally sufficient portion of the
protein capable of efficiently targeting CAT to mitochon-
dria and, similar to wild-type p36, is localized to the outer
membranes of mitochondria in an Nout-Cout topology
(refer to Additional files 2A and 2B for high-magnification
CLSM and differential permabilization assays with p36
90-190-CAT).
Characterization of the mitochondrial targeting informa-
tion in p36 was also carried out using domain-swapping
assays with TBSV p33, an ortholog of CymRSV that has
been recently well characterized in terms of its peroxiso-
mal membrane targeting signal [25]. Alignment of the
deduced amino acid sequences for p36 and p33 revealed
that while these proteins are nearly identical in their C-ter-
minal halves, they are significantly divergent with respect
to their N termini (Figure 4A). For instance, although
both proteins are predicted to contain two TMDs located
at relatively similar positions within their N-terminal
halves (underlined, Figure 4A), p36 also possesses a
number of amino acid residues in this region of the pro-
tein that are not found in p33. The most conspicuous of
these being stretches of unique residues located near the
extreme N terminus and within the intervening loop
sequence of p36 (Figure 4A). Alignment of the p36 and
p33 sequences revealed also that the multiple targeting
signal motifs responsible for sorting nascent p33 initially
to peroxisomes (i.e., -K11K12-, K76RRQR80- and -
R124PSVPKK130-) (shaded in grey in Figure 4A) and then
from peroxisomes to a subdomain of the endoplasmic
Localization of p36-CAT fusion proteins in BY-2 cellsFigure 3
Localization of p36-CAT fusion proteins in BY-2 cells. (A) Schematic illustrations of CAT and various p36-CAT fusion proteins and their corre-
sponding subcellular localizations in transformed (via biolistic bombardment) BY-2 cells. The numbers in the name of each fusion construct denote the spe-
cific amino acid residues from p36 that were fused to the N terminus of CAT. Portions of the p36 ORF are colored blue or black, the latter denoting the 
two putative TMDs in p36 and the numbers shown above p36-CAT include the position of each TMD's left and right amino acid border. Grey boxes 
denote CAT. Mito, mitochondria; Cyt, cytosol. (B) Representative (immuno)epifluorescence micrographs illustrating the localizations of the various con-
structs shown in (A). Each micrograph is labelled at the top left with the name of the transiently-expressed fusion protein or the endogenous mitochon-
drial marker protein, E1β. Hatched boxes represent the portion of the cells shown at higher magnification in the panels to the right. Arrowheads indicate 
obvious colocalizations. Bar = 10 μm.Page 6 of 26
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Figure 4
Localization of p36-p33 hybrid proteins in BY-2 cells. (A) Alignment of the deduced amino acid sequences of CIRV p36 and TBSV p33. Sequences 
were obtained from GenBank and aligned using the ClustalW http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_clustalw.html. Identical amino 
acids in each protein are indicated with asterisks and putative TMDs (underlined) were determined using TMHMM (version 2.0) and visual inspection. 
Clusters of amino acids in TBSV p33 that were reported previously [25] to constitute the peroxisomal (i.e., -K11K12-, K76RRQR80- and -R124PSVPKK130-) 
or pER (i.e., -K5R6-) targeting signals are shaded grey or bolded, respectively. Conserved residues in p33 (residues 184–203) and p36 (residues 218–237) 
that are immunorecognized by a polyclonal antibody raised against this (synthetic) peptide sequence [25] are italized and bolded. (B) Schematic illustra-
tions of C-terminal myc-tagged p36 (p36-myc), p33 (p33-myc) and various p36-p33 hybrid proteins and their corresponding subcellular localizations in 
transformed (via biolistic bombardment) tobacco BY-2 cells. The numbers in the name of each hybrid construct denote the specific amino acid residues 
from p36 or p33 that were fused to (trunctated) p33-myc or p36-myc, respectively. Portions of the p36 ORF are colored blue or black, the latter denoting 
the two putative TMDs in p36 and the numbers shown above p36-myc indicating their relative amino acid positions. Similarly, portions of the p33 ORF are 
colored white and red, the latter denoting the two putative TMDs in p33 and the numbers shown above p33-myc indicating their relative amino acid posi-
tions. The grey colored box for each construct denotes the C-terminal appended myc epitope. Cyt, cytosol; Mito, mitochondria; Perox, peroxisome. (C) 
Representative (immuno)epifluorescence micrographs illustrating the localizations of the various constructs shown in (B). Each micrograph is labelled at 
the top left with the name of either the transiently-expressed protein, the endogenous mitochondrial matrix marker protein E1β, or the endogenous per-
oxisomal matrix marker protein catalase. Hatched boxes represent the portion of the cells shown at higher magnification in the panels to the right. Solid 
arrowheads indicate obvious colocalizations; open arrowheads indicate obvious non-colocalizations. Bar = 10 μm.
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K5R6-) (bolded in Figure 4A) [25] are not conserved in
p36, consistent with the apparently distinct intracellular
sorting pathways employed by these two proteins.
As shown in Figures 4B and 4C, p36-myc and p33-myc
(TBSV p33 appended to a C-terminal myc-epitope tag)
sorted exclusively to aggregated mitochondria and perox-
isomes, respectively, in transiently-transformed BY-2 cells.
The aggregation of peroxisomes in p33-myc-transformed
cells is apparent by comparing the immunostaining pat-
tern attributable to the endogenous peroxisomal matrix
enzyme catalase in these cells with that of p36-myc-trans-
formed cells, wherein catalase-containing peroxisomes
display a normal (punctate) morphology and distribution
(Figure 4C). These data for the localization of p33-myc to
altered peroxisomes was expected, since previously pub-
lished results with wild-type (non-tagged) p33 expressed
for the same length of time (i.e., 4 h following biolistic
bombardment) revealed that it was localized exclusively
to peroxisomes and caused the organelles to coalesce [25].
Also similar to wild-type p33 [25], p33-myc sorted from
peroxisomes to pER at later time points following bom-
bardment (i.e., 24 h) (data not shown), indicating that
the myc epitope also did not disrupt the normal peroxi-
some-to-pER sorting of the protein. Nevertheless, in order
to minimize any potential sorting complexities associated
with the targeting of p33 from peroxisome to pER at later
time points, all of p33/p36-myc hybrids employed in
domain-swapping assays were assessed only at 4 h post-
bombardment for peroxisomal versus mitochondrial tar-
geting.
Replacement of the N-terminal half of p33 (residues 1–
156) with the corresponding sequences from p36 (resi-
dues 1–190), including the N-terminal hydrophilic
domain and both TMDs plus the intervening loop
sequence, resulted in the hybrid protein (p36 1–190 p33-
myc) being sorted to aggregated mitochondria, but not to
peroxisomes (Figure 4C). Conversely, p33 1–156 p36-
myc, consisting of the N-terminal half of p33, including
all three of the protein's peroxisomal targeting signals
(i.e., -K11K12-, K76RRQR80- and -R124PSVPKK130-; refer to
Figure 4A) [25], fused to the C-terminal half of p36, sorted
exclusively to peroxisomes in a manner similar to full-
length p33-myc (Figure 4C).
Figures 4B and 4C show also that fusion of the N-terminal
120 amino acids of p36 (including the protein's N-termi-
nal hydrophilic domain and first TMD) to the remaining
C-terminal portion of p33-myc resulted in the hybrid pro-
tein (p36 1–120 p33-myc) being localized to the cytosol,
a result similar to when this N-terminal region of p36 was
fused to CAT (p36 1-120-CAT) (Figure 3). Localization to
the cytosol was observed also when the intervening loop
sequence from p36 was replaced with the loop sequence
from p33 (p33 103–131 p36-myc), indicating that this
region of p36 contains essential mitochondrial targeting
information. In accordance with this premise, the p36
intervening loop sequence together with its second TMD
was capable of redirecting, albeit inefficiently, p33-myc to
mitochondria, i.e., p36 120–190 p33-myc was sorted to
both mitochondria and peroxisomes (Figure 4C), and fur-
ther showing that this hybrid protein contains targeting
information for both organelles. By contrast, mitochon-
drial targeting of p36 was completely abolished when its
intervening loop sequence and TMD2 was replaced with
the corresponding sequences from p33 (residues 103–
156), i.e., p33 103–156 p36-myc was not localized to
mitochondria, but instead localized to both peroxisomes
and the cytosol (Figure 4C). The apparent inefficient sort-
ing of this hybrid protein to peroxisomes is likely due to
the fact that it possessed only one of the three peroxisomal
targeting signals within p33, i.e., -R124PSVPKK130- (refer to
p33 sequence shown in Figure 4A).
Overall, the data presented in Figures 3 and 4 confirm and
extend the observations of Weber-Lotfi et al. [18] that the
minimally sufficient mitochondrial targeting information
in p36 is located within protein's N-terminal half, includ-
ing both TMDs and the intervening loop sequence. Addi-
tional flanking sequences immediately upstream and
downstream of TMD1 and TMD2, respectively, are not
essential, however, for targeting p36 to mitochondria. For
instance, the N-terminal hydrophilic portion of p36 was
insufficient in sorting CAT (Figure 3) or a p36/p33 hybrid
protein containing the remaining C terminal portion of
p33 (Figure 4) to mitochondria. Thus, our data contradict
the previously proposed notion that the N-terminal
hydrophilic domain of p36, specifically, the residues
immediately upstream of TMD1, contain a distinct mito-
chondrial targeting determinant [18]. It appears instead
that p36 contains only one mitochondrial targeting sig-
nal: a signal that consists of a relatively large portion of
the protein (residues 90–190) and includes several differ-
ent structural elements, i.e., two TMDs and an intervening
soluble loop sequence. The relative contribution of these
elements likely mediates the various aspects of p36 bio-
genesis including maintaining solubility before mem-
brane insertion, targeting to mitochondria, and/or
ensuring proper assembly in the mitochondrial outer
membrane.
The moderate hydrophobicity of TMD1 and TMD2 is 
essential for targeting p36 to mitochondria
The results presented above indicate that the sorting of
p36 to mitochondria is, at least in part, dependent upon
its TMDs. Thus, to test whether specific amino acid
sequences or more global properties, e.g., overall hydro-
phobicity and/or length, within one or both of the TMDsPage 8 of 26
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tion, we generated several different mutant versions of
p36-myc containing altered TMD sequences (Figure 5A).
Included among these p36 TMD mutants were those that
contained sequences derived from either TBSV p33 or the
mitochondrial outer membrane-localized isoform of
cytochrome b5 (Cb5), a tail-anchored protein whose mito-
chondrial targeting signal consists of several unique phys-
icochemical and sequence-specific characteristics within
its single C-terminal TMD and hydrophilic tail domain
[27]. By replacing TMD1 or TMD2 in p36 with either the
corresponding TMDs from p33 or the TMD from Cb5
(and vice versa, i.e., Cb5 with its TMD exchanged for
TMD1 or TMD2 from p36), we sought to determine what
role the p36 and p33 TMDs play in mitochondrial versus
peroxisomal targeting and, in the case of p36 and Cb5,
whether these two proteins possess functionally equiva-
lent mitochondrial targeting information within their
TMDs.
As shown in Figure 5B, when the sequences for TMD1 and
TMD2 in p36 were exchanged the resulting mutant pro-
tein (p36-myc TMD1 ⇔ TMD2) localized exclusively to
mitochondria. Interestingly, the morphology and distri-
bution of the mitochondria in these cells, unlike in wild-
type p36-myc-transformed cells (refer to Figure 1), did not
Localization of p36 and Cb5 proteins with modified TMDs in BY-2 cellsFigure 5
Localization of p36 and Cb5 proteins with modified TMDs in BY-2 cells. (A) Schematic illustrations of various p36-myc and myc-Cb5 proteins 
with modified TMDs and their corresponding subcellular localizations in transformed (via biolistic bombardment) BY-2 cells. The name of each mutant 
construct denotes p36-myc or myc-Cb5 and the specific alterations to its TMD(s). Hydrophilic portions of the p36 ORF are colorized blue, with TMD1 
and TMD2 in p36 colored black and white, respectively. The single TMD in Cb5 is colorized red. Grey boxes denote the position of the myc epitope. Cyt, 
cytosol; ER, endoplasmic reticulum; Mito, mitochondria; ?, unknown subcellular compartment(s). (B) Representative (immuno)epifluorescence micro-
graphs illustrating the localizations of the various constructs shown in (A). Each micrograph is labelled at the top left with the name of either the tran-
siently-expressed protein, the endogenous mitochondrial marker protein, E1β, the endogenous peroxisomal marker protein, catalase, or ConA (fluor-
conjugated Concanavalin A) serving as stain for the ER [89,98]. Hatched boxes represent the portion of the cells shown at higher magnification in the 
panels to the right. Solid arrowheads indicate obvious colocalizations; open arrowheads indicate obvious non-colocalizations. Bar = 10 μm.Page 9 of 26
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that the relative positions of the two TMDs within p36
influence the effects that this protein has on mitochondria
morphology/distribution, but not its intracellular sorting.
An examination of the TMD amino acid sequences within
p36 (underlined, Figure 4A) did not reveal any noticeable
conserved features. For instance, with the exception that
both TMDs possess similar (moderate) average hydropho-
bicity indexes (according to the Kyte-Doolittle algorithm
[28]) of 1.58 (TMD1) and 2.05 (TMD2), they vary in their
overall length (i.e., TMD1 is predicted to be 18 amino acid
residues long, whereas TMD2 is 23 residues long). More-
over, they contain no obvious conserved amino acid
sequence-specific motifs or an enrichment of particular
amino acid residues. Therefore, the possibility was tested
that the overall hydrophobic nature of the TMDs was the
functional determinant in sorting p36 to mitochondria.
Toward this end, either TMD1 or TMD2, or both TMDs
together, in p36 were replaced with artificial (idealized)
amino sequences composed of multiple -LALV-repeats
[29] while still maintaining the length of the TMDs in
p36, i.e., 18- and 23-long repeats of -LALV-corresponding
to the length of TMD1 and TMD2 in p36, respectively. As
shown in Figure 5B, all three of the resulting mutant ver-
sions of p36-myc (i.e., p36-myc TMD1ΔsynTMD, p36-
myc TMD2ΔsynTMD and p36-myc TMD1/
TMD2ΔsynTMD) mislocalized to cytosol and to some
unknown punctate compartment(s) that did not colocal-
ize with endogenous mitochondrial E1β (refer to open
arrowheads in high magnified views shown in Figure 5B),
nor peroxisomal catalase (data not shown). Similarly,
replacement of TMD1 or TMD2 in p36 with the 18 amino-
acid long single TMD from the mitochondrial isoform of
Cb5 [27] resulted in both mutant proteins (p36-myc
TMD1ΔCb5TMD and p36-myc TMD2ΔCb5TMD) being
mislocalized to the cytosol. By contrast, both p36-myc
TMD1Δp33TMD1 and p36-myc TMD2Δp33TMD2 in
which TMD1 or TMD2 of p36 were replaced with TMD1
or TMD2 from p33, respectively, sorted to (aggregated)
mitochondria in a manner similar to wild-type p36-myc
(Figure 5B).
As shown also in Figure 5B, N-terminal myc-tagged Cb5
(myc-Cb5) localized exclusively to mitochondria, as pre-
viously published [27]. Replacement of the single TMD in
myc-Cb5 with TMD1 or TMD2 from p36, however,
resulted in the corresponding mutant proteins being mis-
localized either to the cytosol (myc-Cb5Δp36TMD1) or to
the ER (myc-Cb5Δp36TMD2) (Figure 5B); although in a
small proportion (~15%) of the cells transformed with
myc-Cb5Δp36TMD2 the mutant protein targeted to mito-
chondria in a manner similar to that of wild-type myc-
Cb5 (Figure 5B).
Together, the data presented in Figure 5 imply that not all
hydrophobic sequences are sufficient to replace TMD1 or
TMD2 in p36 in terms of mediating its proper targeting to
mitochondria. However, a pertinent question based on
these data is why the TMDs from p33, a peroxisomal
membrane-localized protein [15,25,30,31], but not an
idealized hydrophobic TMD, nor the TMD from an
authentic mitochondrial outer membrane protein Cb5
[27], are capable of preserving the targeting of p36 to
mitochondria? One possibility is that the relatively mod-
erate overall hydrophobicity of the TMDs in p36 is an
essential feature of the protein's mitochondrial targeting
signal. Based on this premise, the mislocalization of p36
when one (or both) of its TMDs was replaced with either
an artificial TMD(s) or the Cb5 TMD was due to the rela-
tively high hydrophobic indexes of these introduced
sequences, i.e., 3.33 and 3.36 for the 18 and 23 amino
acid-long synthetic TMDs and 2.42 for the 18 amino acid-
long Cb5 TMD, compared to those for p36 TMD1 (1.58)
and TMD2 (2.05). By contrast, the mitochondrial target-
ing of p36 was not disrupted when its TMDs were replaced
individually with the relatively moderate hydrophobic
TMDs from p33, i.e., 2.01 and 1.98 for TMD1 and TMD2,
respectively.
This scenario that the mitochondrial sorting of p36 is
mediated, at least in part, by the moderate hydrophobic
nature of its TMDs is in agreement with results from sev-
eral other studies on the sorting of authentic mitochon-
drial outer membrane proteins. That is, depending on the
protein, a moderate hydrophobic TMD(s), combined
with positive charges at its flanking soluble regions, is
essential for mitochondrial outer membrane targeting
[reviewed in [32,33]]. For example, the 20-kD and 70-kD
subunits of the TOM complex (TOM20 and TOM70) and
TOM45 (a mitochondrial outer membrane protein of 45
kD) from yeast all contain moderately hydrophobic
TMDs that are functionally interchangeable in terms of
their targeting behaviour [34]. The mammalian (human)
TOM20 and yeast mitochondrial outer membrane protein
fission 1 (FIS1) also appear to rely on the moderate hydro-
phobicity of their TMDs, since increasing their overall
hydrophobic score via mutagenesis resulted in both mod-
ified proteins being mislocalized [35,36]. Conversely,
reducing the overall hydrophobicity of an artificial TMD
within a yeast ER-localized reporter membrane protein by
introducing one or more hydrophilic residues caused it to
relocalize from the ER to mitochondria [37].
A notable extension of this model is that, for at least some
mitochondrial outer membrane proteins, they appear to
rely also on subtle sequence-specific features within their
TMDs. For instance, both the yeast 5-kD and 7-kD TOM
subunits (TOM5 and TOM7) possess a conserved proline
residue near the center of their TMDs that is required forPage 10 of 26
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the precise role of this proline in the mitochondrial target-
ing of these proteins has not been determined, it may be
due to the residue's ability to destabilize the TMD's α-hel-
ical structure and, thus, dictate its overall configuration
and subsequent interaction with the proper cognate
receptor and/or integration/assembly factor(s) [32]. Inter-
estingly, targeting of mitochondrial plant Cb5 also
appears to rely on a conserved proline residue that forms
part of a short hydrophilic surface situated within the pro-
tein's TMD [27]. Based on this, it is perhaps not surprising
that replacement of the Cb5 TMD with either TMD1 or
TMD2 from p36 resulted in both of the modified Cb5
proteins being either completely (myc-Cb5Δp36TMD1)
or partially (myc-Cb5Δp36TMD2) mislocalized within
cells (Figure 5B). That is, the nature of the targeting infor-
mation within the TMDs of p36 and Cb5 appear to be suf-
ficiently distinct in terms of their relative overall
hydrophobicity and the presence (or the lack) of
sequence-specific motifs, such that they are not function-
ally interchangeable. As discussed below, these apparent
differences in the targeting elements within the TMDs of
p36 and Cb5 also appear to reflect the relative contribu-
tion of unique positively-charged targeting elements at
their flanking regions.
The intervening loop sequence of p36 contains an 
amphipathic helix with a positively-charged face that is 
essential for mitochondrial targeting
Since the intervening loop sequence in p36 (residues
120–165 between TMD1 and TMD2) is significantly
divergent from the corresponding loop sequence in perox-
isomal-targeted p33 (Figure 4A) and since replacement of
this region in p36 with that from p33 resulted in the
hybrid protein (p33 103–131 p36-myc) being mislocal-
ized to the cytosol (Figure 4B), we analyzed this region in
p36 to determine if it contained any distinctive features
involved in mitochondrial targeting. Figure 6A shows that
Localization of p36 intervening-loop mutants in BY-2 cellsFigure 6
Localization of p36 intervening-loop mutants in BY-2 cells. (A) Deduced amino acid sequence of the intervening loop sequence (residues 120–
165) and portions of the immediately-adjacent TMDs (underlined) in p36. The numbers shown above individual amino acids indicate their relative positions 
in p36. Amino acids predicted to form an α-helix (residues 131–157) are shaded grey and residues that are proposed to constitute the positively-charged 
face of the α-helix are bolded. Secondary structure prediction was carried out using Jpred http://www.compbio.dundee.ac.uk/~www-jpred/. Numbers next 
to each amino acid residue shown in the α-helical wheel projection correspond to their relative positions in p36 (residues 121–157) beginning at the N-
terminal end of the predicted α-helix. Positively-charged residues in the α-helix are colored red. (B) Schematic illustrations of various p36-myc mutant 
proteins and their corresponding subcellular localizations in transformed (via biolistic bombardment) tobacco BY-2 cells. The numbers in the name of each 
p36 mutant denote the specific amino acid residues that were either deleted or replaced with glycine residues. Portions of the p36 ORF are colorized blue 
or black, the latter denoting the two putative TMDs in p36. Asterisks highlight the relative position of the cluster of positively-charged amino acids that 
were replaced with glycine residues. Grey boxes denote the C-terminal myc epitope. Cyt, cytosol; Mito, mitochondria. (C) Representative (immuno)epif-
luorescence micrographs illustrating the localizations of the various constructs shown in (B). Each micrograph is labelled at the top left with the name of 
either the transiently-expressed protein or the endogenous mitochondrial marker protein, E1β. Hatched boxes represent the portion of the cells shown 
at higher magnification in the panels to the right. Arrowheads indicate obvious colocalizations. Bar = 10 μm.Page 11 of 26
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loop, specifically the central portion of this sequence that
is devoid in p33 (residues 131–157, shaded in Figure 6A;
refer also to Figure 4A), is enriched in both positively-
charged (bolded) and hydroxylated (i.e., Ser, Thr and Pro)
amino acid residues. This central region of the p36 inter-
vening loop also has the propensity (based on secondary
structure prediction programs) to form an α-helix, one
with amphipathic characteristics conveyed by a positively-
charged face (refer to amino acid residues in red; Figure
6A).
Based on these observations and previous reports that the
targeting of several other authentic mitochondrial outer
membrane-destined proteins rely on positively-charged
residues together with a flanking TMD(s) [32,33], we
examined further the positively-charged face of the
amphipathic helix in p36 by mutational analyses. As
shown in Figures 6B and 6C, deletion of amino acid resi-
dues 131–157 in p36-myc resulted in the mutant (i.e.,
p36-mycΔ131-157) being mislocalized to the cytosol.
These data are consistent with the mislocalization of p36-
myc when its intervening loop sequence was replaced
with that of p33 (i.e., p33 103–131 p36-myc; Figure 4B).
Mitochondrial targeting of p36-myc was also abolished
when glycine residues were exchanged for each of the four
positively-charged residues predicted to be situated along
the same face of the amphipathic α-helix within the pro-
tein's intervening loop sequence, i.e., p36-myc
K134K137R144K151ΔG mislocalized to the cytosol (Figure
6C). By contrast, glycine substitutions of another cluster
of positively-charged residues (i.e., K93K94R98R101) located
immediately upstream of TMD1 did not disrupt the sort-
ing of p36-myc to mitochondria (p36-myc
K93K94R98R101ΔG; Figure 6C). These latter results, as well
as those presented earlier for the mislocalization of p36 1-
120-CAT (Figure 3) and p36 1–120 p33-myc (Figure 4)
reinforce our conclusion that, in contrast to the findings
reported by Weber-Lotfi et al. [18], the N-terminal
hydrophilic region located upstream of TMD1 in p36
does not contain mitochondrial targeting information.
The results for p36-myc K93K94R98R101ΔG also indicate
that not all mutations to the protein affected its mito-
chondrial targeting fidelity. An observation that under-
scores a substantive caveat of this study (and any analysis
of membrane protein targeting) whereby mutations of
p36 that resulted in the protein's mislocalization could
have been due to aberrant protein folding, rather than a
disruption of a specific targeting determinant(s).
Although this possibility cannot be excluded, our com-
bined use of loss-of-function and gain-of-function target-
ing assays strongly supports our definition of the bona fide
mitochondrial targeting information within p36.
Collectively, our findings on the combined importance of
positively-charged residues (Figure 6) and moderate
hydrophobic TMDs (Figure 5) in the mitochondrial tar-
geting of p36, as well as the Nout-Cout topological orienta-
tion of the protein in the mitochondrial outer membrane
(Figure 2), suggests that the insertion and assembly of p36
involves a signal loop-anchor mechanism [40]. That is,
interaction of the positively-charged residues in the inter-
vening loop sequence of nascent p36 with the mitochon-
drial outer surface might promote a conformational
change that drives insertion of its moderate hydrophobic
TMDs into the bilayer, and results in the proper Nout-Cout
topology. This proposed signal loop-anchor mechanism
is consistent, as mentioned above, with results from pre-
vious in vitro insertion experiments with p36 and isolated
mitochondria [18]. Moreover, since the topological orien-
tation of p36 is identical to the topology of the authentic
outer mitochondrial membrane proteins yeast fuzzy
onion 1 (Fzo1) and its mammalian homologs, mitofusin
(Mfn) 1 and 2, i.e., anchored in an Nout-Cout manner by
two α-helical TMDs connected via a short loop sequence
located in the intermembrane space [41,42], it is possible
that the signal loop-anchor insertion of p36 is mediated
by the same mitochondrial machinery that is utilized by
Fzo1 and Mfn1/2. Results of experiments aimed at
addressing this possibility are described next.
p36 interacts with certain components of the 
mitochondrial TOM complex, but not with the 
mitochondrial SAM complex
Almost all mitochondrial proteins are encoded by nuclear
genes, synthesized on free polyribosomes in the cytosol,
and targeted post-translationally to the organelle. Thereaf-
ter, the recognition, translocation, and sorting of these
proteins is usually mediated by the TOM complex and,
depending on the protein's submitochondrial destina-
tion, one of several other translocase complexes located in
the outer and inner mitochondrial membranes [reviewed
in [43-45]]. For instance, based on studies carried out pri-
marily with yeast and mammalian model systems, it is
well established that nascent proteins destined for the
mitochondrial matrix or inner membrane are recognized
by the import receptors TOM20 and TOM70 and then
delivered to one of two discrete translocase of the inner
mitochondrial membrane (TIM) complexes. The majority
of proteins destined for the outer mitochondrial mem-
brane in yeast and mammals also rely on the TOM com-
plex, but appear to do so in a number of different ways
depending on their topology [reviewed in [33]]. For
example, mitochondrial outer membrane proteins with
multiple α-helical TMDs, including Mfn1/2, utilize the
receptor TOM70, but not other components of the TOM
complex [46]. β-barrel outer mitochondrial membrane
proteins, such as porin and the channel forming subunit
of the TOM complex, TOM40, as well as C-terminal tail-Page 12 of 26
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TOM5, TOM6 and TOM7), are recognized mainly by
TOM20 and then subsequently transferred to the SAM
complex [47], a hetero-oligomeric complex located in the
mitochondrial outer membrane where it functions in β-
barrel protein insertion and assembly [33,48]. Interest-
ingly, another subset of C-terminal, tail-anchored outer
membrane proteins, including BAX and FIS1, do not
require any known import (TOM) components, but
instead appear to rely on the unique lipid composition of
the mitochondrial outer membrane for their proper tar-
geting and insertion [49,50].
While it is generally accepted that the various mitochon-
drial import pathways and associated machinery are con-
served among evolutionarily diverse organisms including
yeast, animals and plants, considerable differences exist
among some of their core protein subunit compositions
and functional specificities, particularly in plants [51,52].
Thus, p36 may or may not use the same mitochondrial
insertion machinery in plants as that employed by multi-
spanning mitochondrial outer membrane proteins in
yeasts and mammals, such as the TOM70-dependent tar-
geting of Mfn1/2 [46]. The targeting and insertion of p36
may be also more similar to that of yeast FIS1, which is
mediated primarily by the distinct lipid composition of
the mitochondrial outer membrane [50], a possibility that
appears to be consistent with previous data indicating that
p36 does not to rely on any mitochondrial-surface pro-
teinaceous receptors [18]. This latter conclusion, however,
was based solely on the observation that pre-treatment of
isolated mitochondria with trypsin to remove any
exposed parts of surface receptors did not prevent mem-
brane insertion of p36. Indeed, this apparent lack of sen-
sitivity to trypsin is not evidence a priori that p36 import
does not utilize a proteinaceous receptor(s), since mito-
chondrial surface receptors can display differences in
terms of their sensitivity/resistance to an applied protease
[53,54] and can even be bypassed in vitro such that a chlo-
roplast protein can be imported into protease-pretreated
mitochondria with the same efficiency as a mitochondrial
protein that normally relies on a surface receptor [55].
To determine the insertion pathway of p36 into the outer
mitochondrial membrane we tested whether it could
interact directly with a variety of protein components of
the plant TOM and/or SAM complexes. Specifically, we
employed bimolecular fluorescence complementation
(BiFC) assays to determine whether in vivo physiological
interactions occur between p36 and four Arabidopsis TOM
protein subunits including: i) the TOM20 import receptor
[56-58]; ii) TOM22, which may function in a manner sim-
ilar to yeast and mammalian TOM22 by providing some
receptor function, but mostly as a link between the pri-
mary receptors TOM20 and TOM70 [59]; iii) TOM40, the
central pore-forming subunit of the TOM complex [56];
and iv) mtOM64 (outer mitochondrial membrane pro-
tein of 64-kD), which functions as an import receptor
and, based on structural similarities, may be a paralog of
yeast and mammalian TOM70 [52,60]. We also tested
whether p36 physically interacts with Arabidopsis
METAXIN, a diverged form of the SAM component
SAM37 and METAXIN1 in yeasts and mammals, respec-
tively [52,61].
BY-2 cells were transiently transformed with pairs of plas-
mids encoding p36 fused at its C terminus to the C-termi-
nal half of the modified yellow fluorescent protein Venus
[62] (cVenus) and one of the TOM or SAM proteins fused
at either their N or C termini to the N-terminal half of
Venus (nVenus) (e.g., nVenus-TOM20); refer to illustra-
tions of various proteins in Figure 7B showing their pre-
dicted topological orientations in the mitochondrial outer
membrane and the relative location of their appended
Venus fragment. Because each half of Venus is not intrin-
sically fluorescent, Venus fluorescence is observed only
when intermolecular interactions occur between nVenus-
and cVenus-tagged proteins [63-65], highlighting an
advantage of BiFC over other protein-protein interaction
assays (e.g., yeast two-hybrid and immunoprecipitations)
in that the subcellular localization of the interacting pro-
teins can directly be observed in living cells via micros-
copy. All cells were also co-bombarded with a third
plasmid encoding the red fluorescent protein (RFP),
which served as an internal standard for transformation
efficiency and aided in identifying transformed cells.
Alternatively, BY-2 cells were co-bombarded with a plas-
mid coding for an individual nVenus- or cVenus-tagged
protein along with a plasmid encoding βATPase-GFP
(consisting of the N-terminal mitochondrial matrix target-
ing presequence of βATPase [residues 1–60] fused to the
N terminus of GFP), which served to identify transformed
cells and, acting as a well-characterized mitochondrial
marker protein [66,67]. As presented in Additional file
3A, results from these latter experiments provided confir-
mation of the expression of each of the individual Venus
half fusion proteins (via immunomicroscopy of an
appended myc or hemaglutinin (HA)-epitope tag; see
Methods and Materials for details on the construction of
BiFC plasmids), as well as their mitochondrial localiza-
tion. Additional results confirming the topological orien-
tation of several of these Venus half fusion proteins in BY-
2 cells using the differential detergent permeabilization
assay are presented in Additional file 3B.
The results presented in Figure 7A show that p36 (i.e.,
p36-cVenus) interacted in vivo with all three of the nVe-
nus-tagged versions of the putative import receptors,
TOM20, TOM22 and mtOM64. Notably, the interactionPage 13 of 26
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protein's N-terminal tetratricopeptide motif-based
domain responsible for the recognition and interaction
with mitochondrial precursor proteins (residues 1–142;
[58]) was deleted (TOM20mut), suggesting that the inter-
action of p36 with the TOM20 is not mediated by this
substrate-receptor-binding motif. p36 did not interact,
however, with either TOM40, the SAM component
METAXIN, or itself (i.e., p36-nVenus) (Figure 7A). While
these latter data appear to contradict those published else-
where for the homo-oligmerization of the p36-related
protein, TBSV p33 [[68] and references therein] and, p36-
p36 and other p36-protein interactions likely occur
within the context of the functional CIRV replication com-
plex and, thus, mediated by the allied replication protein,
p95, as well viral RNA template [69].
In a series of control experiments we also evaluated
whether or not the βATPase matrix targeting presequence
and/or the full-length outer mitochondrial β-barrel mem-
brane protein, porin, interacted with the TOM and SAM
complex protein subunits in a manner similar to p36. As
shown in Figure 7A, the data obtained for βATPase and
porin are mostly in accordance with the current working
models for the mitochondrial import pathways used by
these two proteins [43-45,51]. For instance, both βATPase
and porin (βATPase-cVenus and porin-cVenus) interacted
with the nVenus-tagged versions of TOM20, TOM22 and
mtOM64, reflecting the apparent functional redundancy
of these import receptors in plants [52]. Likewise, porin
interacted with the N-terminal mutant version of TOM20
(TOM20mut), but βATPase did not, supporting the
notion that the import of matrix-destined proteins is
dependent primarily on TOM20 via the receptor's N-ter-
minal tetratricopeptide motif domain [56,58]. The rela-
tive importance of the mtOM64 receptor in βATPase and
porin (and p36) import using a similar mutagenesis-BiFC
approach was not, however, assessed, since deletion of the
predicted substrate-receptor binding motif in mtOM64
[60,70] disrupted its sorting to mitochondria in BY-2 cells
(data not shown).
Figure 7A shows also that porin, but not βATPase, inter-
acted with METAXIN, consistent with the proposed role of
this SAM component in the insertion and assembly of β-
barrel proteins in yeasts, mammals and plants [47,48,52].
However, Lister et al. [52] recently showed using pull-
down and yeast two-hybrid assays that METAXIN inter-
acted with a number of plant matrix-destined precursor
proteins as well as β-barrel porin and TOM40, suggesting
BiFC analysis of interactions among p36 and components of the TOM and SAM complexesF gure 7
BiFC analysis of interactions among p36 and components of the TOM and SAM complexes. (A) BY-2 cells were co-transformed (via biolistic 
bombardment) with either p36, the N-terminal mitochondrial matrix targeting presequence of the β subunit of the F1-ATPase (βATPase), porin, p33, or 
Cb5 fused at either their N or C termini to cVenus (columns) and various constituents of the TOM complex (or an N-terminal mutant version of TOM20; 
TOM20mut), METAXIN, or p36 fused at either their N or C termini to nVenus (rows). In addition, all cells were co-transformed with either RFP, which 
served as a convenient means of identifying transformed cells. At ~16 h post-bombardment, cells were formaldehyde fixed and viewed by epifluorescence 
microscopy. Interactions were scored based on either the presence (+) or absence (-) of a BiFC (Venus) signal relative to reconstitution controls in which 
individual Venus half fusion proteins were co-expressed with the corresponding "empty" vector containing nVenus or cVenus fragments alone. All BiFC 
signals observed co-localized with (co)expressed mitochondrial βATPase-GFP. For each pair of plasmids tested, > 25 transformed cells were scored from 
at least two independent transformation (biolistic bombardment) experiments. ND, not determined. (B) Predicted topologies of mitochondrial outer 
membrane proteins used in BiFC experiments, the results of which are presented in (A). Also shown is the localization of the soluble βATPase N-terminal 
mitochondrial targeting presequence in the matrix following import. The topological orientations of mitochondrial outer membrane proteins shown are 
based on differential permeablization results presented either in Figure 2 (for p36), in Additional file 3A (for TOM proteins, METAXIN, and porin) or pub-
lished previously in Hwang et al. [27] (for Cb5). Regions of proteins proposed to be hydrophobic membrane-spanning domains or hydrophilic domains 
facing the cytosol, intermembrane space or matrix were identified using the TMpred program http://www.ch.embnet.org/software/TMPRED_form.html. 
The dashed line in the N-terminal portion of TOM20 represents the region of the receptor that was deleted in the corresponding mutant (TOM20mut); 
specifically, protein's N-terminal 1–142 residues including the tetratricopeptide motif-based receptor domain for mitochondrial precursor proteins [58]. 
Asterisks indicate the relative position of nVenus or cVenus and the immediately adjacent myc- or HA-epitope tag appended to each protein. IMS, inter-
membrane space.Page 14 of 26
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and mammals, performs a variety of roles in plants in
addition to the insertion and assembly of β-barrel mem-
brane proteins. Other than the use of different experimen-
tal approaches in the latter study [52] compared to that
employed here, a reason(s) for the apparent lack of inter-
action between βATPase and METAXIN is not known.
Regardless, these results for βATPase (and p36) and
METAXIN, combined with the negative interaction data
for certain other protein pairs discussed below (e.g., p36
and Cb5) provides convincing evidence that the Venus
fluorescence observed in (positive) BiFC assays (e.g.,
porin and METAXIN) resulted from specific protein-pro-
tein interactions and was not simply a consequence, for
example, of the overexpression of protein pairs localized
to the same intracellular local (i.e., mitochondrial outer
membrane) [65].
At least one unexpected finding from the BiFC experi-
ments presented in Figure 7A was that both βATPase and
porin (and p36) did not interact with TOM40, the puta-
tive primary subunit of the TOM complex import channel
[56]. These results contradict those obtained primarily
from studies with yeasts and mammals, wherein TOM40
participates in the import of most types of mitochondrial
proteins including those destined for the matrix or outer
membrane [43-45]. One possible reason for this apparent
lack of interaction between TOM40 and βATPase and
porin (and p36) is that this putative channel protein,
while being efficiently targeted to mitochondria when
expressed individually in BY-2 cells (see Additional file
3A), was not properly inserted/assembled into functional
TOM complexes and, thus, could not participate in mito-
chondrial protein import. Another possible reason may
be that the nVenus fragment appended to TOM40 (refer
to illustration in Figure 7B) is sterically inaccessible, such
that even if the fusion protein was properly assembled
into the TOM complex it could not interact with cVenus
appended to either co-expressed βATPase, porin or p36.
Unfortunately, since another TOM40 fusion protein with
nVenus appended to its C terminus (TOM40-nVenus) was
not sorted to mitochondria in BY-2 cells (data not shown)
and because no other experimental data has been pub-
lished for the structure and/or function of a plant TOM40,
resolution of this issue remains to be addressed.
In additional control experiments TBSV p33 (p33-cVe-
nus) was not observed to interact with any of the TOM
complex subunit proteins tested nor with p36 (Figure 7A).
These results were entirely expected since p33 sorts to per-
oxisomes and not to mitochondria ([25]; see Additional
Figure 3A for the localization of p33-cVenus in BY-2 cells).
Interactions were also not observed between p36 and
porin or p36 and Cb5 (Figure 7A), indicating that, similar
to the negative results discussed above for βATPase (and
p36) and METAXIN, the positive Venus signals detected
for certain other protein pairs was due to their specific
protein-protein interaction. However, related to these
control experiments with p36, porin and Cb5, it is impor-
tant to note that, whereas Cb5 and p36 are orientated in
outer mitochondrial membranes in an Nout-Cin [27] and
Nout-Cout manner (Figure 2; and [15,18]), respectively,
porin contains two putative TMDs and orientated in an
Nin-Cin manner (Figure 7B; refer also to differential per-
meabilization results for cVenus-porin in Additional file
3B). Thus, while cVenus appended to porin (porin-cVe-
nus) is predicted to be located in the intermembrane
space, nVenus appended to p36 (p36-nVenus) faces the
cytosol (Figure 7B) and, thus, the lack of a BiFC signal for
these two proteins when co-expressed in BY-2 cells was
expected given the physical separation of their corre-
sponding Venus halves [65].
Taken together, the BiFC results presented in Figure 7A
indicate that p36 interacts with a variety of import recep-
tors in the TOM complex including TOM20, TOM22, and
mtOM64, consistent with recent findings that, compared
to yeasts and mammals, the mitochondrial import appa-
ratus in plants is highly flexible with overlapping specifi-
city [52]. Our BiFC results indicate also that whereas the
porin interacts with the putative SAM component
METAXIN, p36 (and βATPase) does not. Hence,
METAXIN appears to participate specifically in the assem-
bly of outer mitochondrial membrane proteins contain-
ing a β-barrel structure, a conclusion that extends the
findings presented previously for the role of this mito-
chondrial import component in plants [52].
Conclusion
Viruses are well known for their ability to exploit specific
organelles and pathways in infected host cells in order to
facilitate their replication [1-3]. Here we showed that p36,
an essential component of the CIRV replication complex
and a key factor involved in the virus' ability to transmog-
rify mitochondria into MVBs in infected plant cells, con-
tains a prototypic mitochondrial outer membrane
targeting signal. That is, similar to the targeting signals
characterized for most authentic mitochondrial outer
membrane proteins in evolutionarily diverse organisms
[32,33], the p36 targeting signal consists of a cluster of
positively-charged residues flanked by moderately hydro-
phobic TMDs. We showed also that p36 interacts with sev-
eral TOM components, specifically the import receptors
TOM20, TOM22 and mtOM64. These results, combined
with the apparent conservation of a functional outer mito-
chondrial targeting signal in p36, indicate that CIRV has
evolved a strategy to utilize the host-cell mitochondrial
sorting pathways in order to control or modulate the bio-
genesis and/or function of the organelle to its own advan-
tage. For instance, mitochondrial-derived MVBs in CIRV-Page 15 of 26
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work or platform for replication complex assembly and/
or provide a sophisticated protective structure that shields
the nascent viral RNA or viral replication proteins from
degradation. Both of these possibilities have been pro-
posed previously for other viruses that also rely on the
mitochondrial outer membrane for their replication [71-
75].
While the functional significance of the CIRV-mitochon-
dria relationship and the molecular mechanisms underly-
ing the membrane rearrangements that occur during
mitochondrial MVB biogenesis in CIRV-infected cells
remain to be elucidated, future studies aimed at under-
standing these processes, similar to results presented here
for the sorting of p36, will undoubtedly provide insights
to certain aspects of normal mitochondrial biogenesis in
plant cells (e.g., membrane remodelling during mito-
chondria fission). To date, only one plant outer mito-
chondrial membrane protein, Cb5, has been well
examined in terms of its targeting signal and insertion
mechanism [27,76-78]. Thus, as other plant outer mito-
chondrial membrane proteins begin to be investigated,
including those identified using proteomic- and/or bioin-
formatics-based approaches [79-83], the properties of the
p36 targeting signal and its import mechanism will serve
as a useful reference.
Methods
Recombinant DNA procedures and reagents
Standard recombinant DNA procedures were performed
as described by Sambrook et al. [84]. Molecular biology
reagents were purchased either from New England
BioLabs (Beverly, MA, USA), Promega (Madison, WI,
USA), Perkin-Elmer (Perkin-Elmer Biosystems, Missis-
sauga, Canada), Stratagene (La Jolla, CA, USA), or Invitro-
gen (Carlsbad, CA, USA). Synthetic oligonucleotides were
synthesized by either Invitrogen (Frederick, MD) or Uni-
versity of Guelph Laboratory Services (Guelph, Canada);
a complete list of the sequences of the oligonucleotides
primer used in plasmid constructions described below are
provided in Additional file 4. Plasmid DNA was isolated
using Qiagen reagents (Qiagen, Mississauga, Canada),
and dye terminated cycle sequencing was used with an
Applied Biosystems Model 377 or 3730 automated
sequencer (Perkin-Elmer Biosystems) to verify all DNA
constructs. Mutagenesis was carried out using appropriate
complementary forward and reverse mutagenic primers
and procedures according to the QuickChange site-
directed mutagenesis kit (Stratagene).
Construction of plasmids
Plasmids containing p36 and/or p95
pRTL2/p36, encoding the CIRV 36 kDa replicase protein
was constructed in the following manner. First, sequences
encoding the p36 ORF were amplified via the polymerase
chain reaction (PCR) (primers Fp135 and Rp107; Addi-
tional file 4) and the plasmid pUC18/CIRV (purchased
from the American Type Culture Collection, clone PVMC-
47) serving as template DNA. This PCR also introduced a
5' NcoI site and a 3' XmaI site that replaced the p36 stop
codon. The resulting PCR products were ligated into
pCR2.1 TOPO (Invitrogen) followed by ligation of the
NcoI-XmaI fragment from the resulting plasmid (pCR2.1
TOPO/p36-XmaI) into NcoI-XmaI-digested pRTL2, a plant
expression vector containing the Cauliflower Mosaic Virus
(CaMV) 35S promoter and terminator and the tobacco
etch potyvirus leader sequence for enhanced translation
[85]. Next, a stop codon was introduced via PCR site-
directed mutagenesis (primers Fp447 and Rp448) at the 3'
end of the p36 ORF in pRTL2/p36-XmaI, yielding pRTL2/
p36.
The C-terminal myc-epitope-tagged version of p36 in
pRTL2 (pRTL2/p36-myc) was constructed by annealing
complementary oligonucleotides (Fp177 and Rp178) that
encoded the myc-epitope tag (-EQKLISEEDL-; [22]), a
stop codon and XmaI overhangs, then ligating these into
XmaI-digested pRTL2/p36-XmaI. An N-terminal myc-
epitope-tagged version of p36 (pRTL2/myc-p36) was con-
structed by annealing complementary oligonucleotides
(Fp29 and Rp30) encoding a start codon, the myc epitope
and NcoI overhangs, and then ligating these into NcoI-
digested pRTL2/p36.
To construct pRTL2/Rep, sequences encoding both CIRV
replicase proteins (p36 and p95) were amplified via PCR
(primers Fp135 and Rp572) from pUC18/CIRV with 5'
NcoI and 3' XmaI sites. The resulting PCR products were
digested with NcoI and XmaI and ligated into NcoI-XmaI-
digested pRTL2, yielding pRTL2/Rep. pRTL2/p95 was gen-
erated by mutating via site-directed mutagenesis (primers
Fp642 and Rp641) the p36 amber stop codon at nucle-
otide positions 1067–1069 to a tyrosine.
An infectious cDNA of CIRV, whereby the sequence for
the entire CIRV genome [8] was cloned between a 5'
CaMV 35S promoter and 3' hepatitis delta virus ribozyme,
was constructed in three steps. First, a unique StuI site was
introduced via site-directed mutagenesis (primers Fp646
and Rp645) upstream of the TBSV sequence in the plas-
mid pHST20 [86], yielding pHST20/StuI-XmaI. Digestion
of this plasmid with StuI and XmaI allowed for the
removal of sequences coding for the entire TBSV genome.
Second, sequences consisting of the first 621 nucleotides
of the CIRV genome were amplified via PCR (primers
Fp735 and Rp734 and pUC18/CIRV as template DNA)
along with a 5' StuI site. The resulting PCR products were
then digested with StuI and SphI by taking advantage of a
unique SphI site within the amplified region of the CIRVPage 16 of 26
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genome (nucleotides 622 to 4760) were excised from
pUC18/CIRV with SphI and XmaI and then this fragment
and the StuI-SphI fragment were ligated together into StuI/
XmaI-digested pHST20/StuI-XmaI, yielding pHST/CIRV.
Plasmids containing p36-CAT or p36-GFP fusion constructs
Construction of p36-CAT fusion constructs was carried
out by first introducing various silent restriction sites at
specific localizations within the p36 ORF. For instance, a
silent MluI site was introduced via PCR site-directed muta-
genesis (primers Fp275 and Rp276) at the 3' end of the
first TMD in the p36 ORF (amino acid residues 119 and
120) to yield pRTL2/p36-myc (MluI). In a second muta-
genesis reaction (primers Fp277 and Rp278) a silent AvrII
site was introduced immediately after the second TMD in
the p36 ORF (amino acid residues 189 and 190) in the
plasmid pRTL2/p36-myc (MluI), yielding pRTL2/p36-
myc (MluI/AvrII).
To construct pRTL2/p36-CAT, encoding the entire p36
ORF fused to the N terminus of CAT, the XmaI site in
pRTL2/p36-XmaI was replaced via site-directed mutagene-
sis (primers Fp340 and Rp341) with an AvrII site to yield
pRTL2/p36-AvrII. Next, the p36 ORF was excised from
pRTL2/p36-AvrII with NcoI and AvrII and ligated into
NcoI/AvrII-digested pRTL2/NcoI/MluI/AvrII-CAT. pRTL2/
NcoI/MluI/AvrII-CAT is a general purpose cassette vector
containing the CAT ORF (minus a start codon) and a con-
venient 5' multiple cloning site (MCS) including in-frame
NcoI, MluI and AvrII sites [25]. pRTL2/p36 1-190-CAT,
encoding the N-terminal 190 residues from p36 fused to
the N-terminus of CAT, was generated by digesting
pRTL2/p36-myc (MluI/AvrII) with NcoI and AvrII and
ligating the resulting fragment into NcoI-AvrII-digested
pRTL2/NcoI/MluI/AvrII-CAT. To generate pRTL2/p36 1-
120-CAT, the CAT ORF was excised from pRTL2/MluI/
AvrII-CAT (a modified version of pRTL2/NcoI/MluI/AvrII-
CAT lacking the unique NcoI site in the MCS; [25]) with
MluI and XbaI (located immediately 3' of the CAT ORF)
and the resulting fragment was ligated into MluI/XbaI-
digested pRTL2/p36-myc (MluI/AvrII). pRTL2/p36 120-
190-CAT was constructed by first replacing via site-
directed mutagenesis (primers Fp331 and Rp332) the
MluI site in pRTL2/p36-myc (MluI/AvrII) with NcoI to
yield pRTL2/p36-myc (MluIΔNcoI/AvrII). pRTL2/p36-myc
(MluIΔNcoI/AvrII) was then digested with NcoI and AvrII
and the resulting fragment corresponding to a start codon
and amino acids 120 to 190 in the p36 ORF was ligated
into NcoI/AvrII-digested pRTL2/NcoI/MluI/AvrII-CAT.
pRTL2/p36 120-190-CAT was then used a template DNA
in a site-directed mutagenesis reaction (primers Fp407
and Rp408) to delete sequences encoding amino acids
166 to 190 in the p36 ORF and corresponding to the p36
TMD2, yielding pRTL2/p36 120-164-CAT. pRTL2/p36 90-
164-CAT and pRTL2/p36 90-190-CAT were constructed
by amplifying via PCR (primers Fp449 and Rp453, and
Fp457 and Rp453-2, respectively), along with pRTL2/p36-
myc (MluIΔNcoI/AvrII) as template DNA, sequences cod-
ing for either amino acids 90 to 164 or 90 to 190 in the
p36 ORF along with 5' NcoI and 3' AvrII sites. Next, the
PCR products were digested with NcoI and AvrII and
ligated into NcoI/AvrII-digested pRTL2/NcoI/MluI/AvrII-
CAT.
Plasmids containing modified versions of p36 or p33
pRTL2/p33 1-156-p36-myc, pRTL2/p33 103-156-p36-
myc and pRTL2/p33 103-131-p36-myc, consisting of p33
amino acids 1 to 156, 103 to 156, and 103 to 131, respec-
tively, within the context of p36-myc, were constructed as
follows. pRTL2/p33 1-156-p36-myc was constructed by
digesting pRTL2/p33-myc (MluI) with NcoI and AvrII and
ligating the resulting fragment into NcoI/AvrII-digested
pRTL2/p36-myc (MluI/AvrII). pRTL2/p33-myc (MluI) is a
modified version of pRTL2/p33-myc [25] in which
codons 104 and 105 in the p33 ORF were replaced via
PCR site-directed mutagenesis (primers Fp273 and
Rp274) with a silent MluI site. pRTL2/p33 103-120-p36-
myc was constructed by digesting pRTL2/p33-myc (MluI)
with MluI and AvrII and ligating the resulting fragment
into MluI/AvrII-digested pRTL2/p36-myc (MluI/AvrII).
pRTL2/p33 103-131-p36-myc was constructed in two
steps. First, annealed complementary oligonucleotides
(Fp1983 and Rp1984) encoding amino acids 103–131
from p33 along with 5' MluI and 3' SalI overhangs were
ligated into MluI-SalI-digested pRTL2/p36-myc (MluI/
SalI/AvrII), yielding pRTL2/p33 103-131-VDMSAR-p36-
myc. Second, sequences encoding the remaining p36
amino acids -VDMSAR- at the 3' end of the loop sequence
in pRTL2/p33 103-131-VDMSAR-p36-myc were removed
using site-directed mutagenesis (primers Fp2007 and
Rp2008). pRTL2/p36-myc (MluI/SalI/AvrII) was gener-
ated by introducing a silent SalI site via site-directed muta-
genesis (primers Fp576 and Rp575) upstream of TMD2 in
the p36 ORF in pRTL2/p36-myc (MluI/AvrII).
pRTL2/p36 1-190-p33-myc, pRTL2/p36 1-120-p33-myc,
and pRTL2/p36 120-190-p33-myc, consisting of p36
amino acids 1 to 190, 1 to 120, and 120 to 190, respec-
tively, within the context of p33-myc, were constructed as
follows. pRTL2/p36 1-190-p33-myc was constructed by
digesting pRTL2/p36-myc (MluI/AvrII) with NcoI and
AvrII and ligating the resulting fragment into NcoI/AvrII-
digested pRTL2/p33-myc (MluI). pRTL2/p36 1-120-p33-
myc was constructed by digesting pRTL2/p36-myc (MluI/
AvrII) with NcoI and MluI and ligating the fragment into
NcoI/MluI-digested pRTL2/p33-myc (MluI). pRTL2/p36
120-190-p33-myc was constructed by digesting pRTL2/
p36-myc (MluI/AvrII) with MluI and AvrII and ligating thePage 17 of 26
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(MluI).
Plasmids encoding modified versions of p36-myc in
which TMD1 and TMD2 were either swapped or replaced
(individually or together) with synthetic TMDs were gen-
erated as follows. pRTL2/p36-myc TMD1 ⇔ TMD2, in
which TMD1 of p36 was replaced with TMD2 of p36 and
vice versa, was constructed by first ligating annealed, com-
plementary synthetic oligonucleotides (Fp654 and
Rp653) coding for p36 TMD2 (amino acids 166–188)
along with 5' SnaBI and 3' MluI overhangs into SnaBI/
MluI-digested pRTL2/p36-myc (SnaBI/MluI/AvrII), yield-
ing pRTL2/p36-myc TMD1ΔTMD2. pRTL2/p36-myc
TMD1ΔTMD2 was then used as template DNA to intro-
duce via site-directed mutagenesis (primers Fp576 and
Rp575) a silent SalI site upstream of TMD2 in the p36
ORF, yielding pRTL2/p36-myc TMD1ΔTMD2-SalI. Next,
two sets of synthetic complementary oligonucleotides
(Fp682 and Rp680, and Fp681 and Rp679) coding for
TMD1 of p36 along with 5'SalI and 3' AvrII overhangs
were annealed and ligated into SalI/AvrII-digested pRTL2/
p36-myc TMD1ΔTMD2-SalI, yielding pRTL2/p36-myc
TMD1 ⇔ TMD2.
pRTL2/p36-myc TMD1ΔsynTMD and pRTL2/p36-myc
TMD2ΔsynTMD, in which TMD1 and TMD2 of p36,
respectively, were replaced with an artificial/idealized
TMD consisting of multiple -LALV-amino acid repeats
[29], were constructed in the following manner. Synthetic
complementary oligonucleotides coding for synthetic
TMDs of the same length as predicted for p36 TMD1 (18
residues) or TMD2 (23 residues), along with either 5'
SnaBI and 3' MluI overhangs (Fp1670 and Rp1672) or 5'
SalI and 3' AvrII overhangs (Fp1674 and Rp1675), were
annealed and ligated into either SnaBI/MluI-digested
pRTL2/p36-myc (SnaBI/MluI/AvrII) or SalI/AvrII-digested
pRTL2/p36-myc (MluI/SalI/AvrII). To construct pRTL2/
p36-myc TMD1/TMD2ΔsynTMD, in which both p36
TMDs were replaced with the artificial/idealized TMDs
composed of -LALV-repeats, pRTL2/p36-myc
TMD2ΔsynTMD was digested with XbaI and the resulting
fragment ligated into XbaI-digested pRTL2/p36-myc
TMD1ΔsynTMD.
pRTL2/p36-myc TMD1ΔCb5TMD was constructed by
ligating annealed complementary oligonucleotides
(Fp1977 and Rp1978) coding for the 18 amino-acid-long
TMD of the tung mitochondrial isoform of Cb5 (isoform
D) [27] with 5' SnaBI and 3' MluI overhangs into SnaBI-
MluI-digested pRTL2/p36-myc (SnaBI/MluI/AvrII). Simi-
larly, pRTL2/p36-myc TMD2ΔCb5TMD was constructed
by ligating annealed complementary oligonucleotides
(Fp1979 and Rp1980) coding for the p36 amino acid
sequence -VDMSARG-immediately adjacent (upstream)
to TMD2 and the tung Cb5 TMD into SalI-AvrII-digested
pRTL2/p36-myc (MluI/SalI/AvrII). pRTL2/myc-Cb5Δp36
TMD1 and pRTL2/myc-Cb5Δp36 TMD2 encoding an N-
terminal myc-tagged version of tung mitochondrial Cb5
with its single C-terminal TMD replaced with either TMD1
or TMD2 from p36 were constructed by ligating annealed
complementary oligonucleotides coding for either the
p36 TMD1 (Fp1960 and Rp1961) or p36 TMD2 (Fp1962
and Rp1963) and the Cb5 C-terminal hydrophilic (tail)
sequence -RKK-COOH, along with a stop codon and 5'
NheI and 3' XbaI overhangs into NheI-XbaI-digested
pRTL2/myc-Cb5. Details on the construction of pRTL2/
myc-Cb5 have been published elsewhere [27].
pRTL2/p36-myc TMD1Δp33TMD was constructed by
ligating annealed complementary oligonucleotides
(Fp113 and Rp114) coding for the p33 TMD1 (residues
84–98) and the amino acid sequence -SYA-immediately
downstream of TMD1 with 5' SnaBI and 3' MluI over-
hangs into SnaBI-MluI-digested pRTL2/p36-myc (SnaBI/
MluI/AvrII). Similarly, pRTL2/p36-myc TMD2Δp33TMD2
was constructed by ligating two sets of annealed comple-
mentary oligonucleotides (Fp130A and Rp131A and
Fp130B and Rp130B) coding for the p33 TMD2 (residues
132–156) with 5' SalI and 3' AvrII overhangs into SalI-
AvrII-digested pRTL2/p36-myc (MluI/SalI/AvrII).
pRTL2/p36-myc Δ 131–157 coding for p36-myc lacking
amino acids residues 131–157 within the intervening
loop sequence was generated using site-directed mutagen-
esis (primers Fp1966 and Rp1967), along with pRLT2/
p36-myc as template DNA. pRTL2/p36-myc
K93K94R98R101ΔG in which the positively-charged amino
acid residues at positions 93, 94, 98 and 101 in the p36
ORF were each replaced with a glycine were constructed
using site-directed mutagenesis (primers Fp412 and
Rp410), along with pRTL2/p36-myc as template DNA.
pRTL2/p36-myc K134K137R144K151ΔG was constructed in
two steps. First, sequences encoding arginine at position
144 and lysine at position 151 in p36-myc (pRTL2/p36-
myc) were mutated to glycines using site-directed muta-
genesis (primers Fp2048 and Rp2049), yielding pRTL2/
p36-myc R144K151ΔG. Second, sequences encoding the
lysines at positions 134 and 137 in pRTL2/p36-myc
R144K151ΔG were mutated to glycines using site-directed
mutagenesis (primers Fp2098 and Rp2099), yielding
pRTL2/p36-myc K134K137R144K151ΔG.
Plasmids used for BiFC
BiFC plasmids used in this study contained fragments
derived from Venus, a variant of the yellow fluorescent
protein (YFP) [62], and were constructed by replacing
sequences encoding the N- or C-terminal fragments from
YFP in the pSATN BiFC series of vectors [63] with
sequences encoding the corresponding Venus N-terminalPage 18 of 26
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selected as the fluorescent protein for these redesigned
BiFC plasmids because, compared to YFP, it does not
require preincubation of cells at lower temperatures to
facilitate efficient chromophore maturation [87]. Moreo-
ver, Venus is brighter than YFP, thus requiring lower
amounts of plasmid(s) for transformations and a shorter
incubation time, features that increase both the BiFC sig-
nal and specificity in terms of protein-protein interactions
[64]. Overall, four different pSATN-based Venus BiFC vec-
tors containing either nVenus or cVenus, an adjacent myc-
or HA-epitope tag [22] serving as convenient means to
immunodistinguish each (co-)expressed fusion protein,
and a 5' or 3' MCS for cloning of the test gene were gener-
ated, including: pSAT4/nVenus C1, pSAT4/nVenus N1,
pSAT4/cVenus C1 and pSAT4/cVenus N1. Details on the
construction of these plasmids are as follows.
To construct pSAT4/nVenus C1, sequences encoding the
N-terminal 174 amino acids of Venus along with intro-
duced 5' NcoI and 3' BglII sites were amplified via PCR
(primers Fp1905 and Rp1922) from pVenus-N1. The PCR
products were digested with NcoI-BglII and ligated into
NcoI-BglII-digested pSAT4-nEYFP-C1 [63] and the result-
ing plasmid was digested with BglII and SacI and ligated
with annealed complementary oligonucleotides (Fp1941
and Rp1946) coding for the myc epitope along with 5'
BglII and 3' SacI overhangs, yielding pSAT4/nVenus C1.
pVenus-N1 (provided by Peter Kim, NIH) was constructed
by disrupting (via site-directed mutagenesis) the Venus
dimerization domain in pVenus-N1-NPY [62] (Nagai et
al., 2002) and then cloning the resulting modified Venus
gene into pEGFP-N1 (Clontech) lacking the GFP ORF. To
construct pSAT4/nVenus N1, sequences encoding the N-
terminal 174 amino acids of Venus, along with an intro-
duced stop codon and 5' BamHI and 3' XbaI sites, were
amplified via PCR (primers Fp1909 and Rp1924) from
pVenus-N1. PCR products were then digested with BamHI
and XbaI and ligated into BamHI-XbaI-digested pSAT4A-
nEYFP-N1 [63] that was isolated from dam- E. coli due to
dam methylation of the XbaI site in the plasmid's MCS.
The resulting plasmid was then digested with SacII and
BamHI and ligated with annealed complementary oligo-
nucleotides (Fp1943 and Rp1944) coding for the myc
epitope along with 5' SacII and 3' BamHI overhangs, yield-
ing pSAT4/nVenus N1. pSAT4/cVenus C1 was generated
by amplifying via PCR (primers Fp1907 and Rp1908 and
pVenus-N1 as template DNA) sequences encoding for the
C-terminal 65 amino acids (residues 175–239) of Venus,
along with a start codon and 5' NcoI and 3' BglII sites. PCR
products were digested with NcoI and BglII and ligated
into NcoI-BglII-digested pSAT2-cEYFP-C1-B [63]. The
resulting plasmid was then digested with BglII and SacI
and ligated with annealed complementary oligonucle-
otides (Fp1942 and Rp1947) coding for the HA eptitope
tag, along with 5' BglII and 3' SacI overhangs, yielding
pSAT4/cVenus C1. pSAT4/cVenus N1 was generated by
amplifying via PCR (primers Fp1911 and Rp1912)
sequences encoding the C-terminal 65 amino acids and
stop codon of Venus, along with introduced 5' BamHI and
3' XbaI sites. PCR products were then digested with BamHI
and XbaI and ligated into dam- BamHI-XbaI-digested
pSAT4A-cEYFP-N1 [63]. The resulting plasmid was
digested with SacII and BamHI and ligated with annealed
complementary oligonucleotides (Fp1945 and Rp1948)
coding for the HA epitope along with 5' SacII and 3'
BamHI overhangs, yielding pSAT4/cVenus N1.
Construction of BiFC plasmids containing TOM20 (or the
mutant version thereof; TOM20mut), TOM22, TOM40 or
METAXIN fused at their N termini to nVenus was carried
out as follows. First, sequences encoding the entire
TOM20, TOM22, TOM40 or METAXIN ORFs were ampli-
fied via PCR using the appropriate oligonucleotide prim-
ers (Additional file 4). Plasmids used as template DNA in
these PCRs included pRTL2/myc-TOM20-III (provided by
P. Dhanoa, University of Guelph), encoding a N-terminal
myc-tagged version of Arabidopsis TOM20 isoform III,
pSPORT1/TOM22-I (ABRC, clone U83367), encoding
isoform I of Arabidopsis TOM22, pUNI51/TOM40-I
(ABRC, clone U11102), encoding isoform I of Arabidop-
sis TOM40, and pUNI51/METAXIN (ABRC, clone
U2140), encoding Arabidopsis METAXIN. All PCRs also
introduced 5' EcoRI and 3' XmaI sites. Resulting PCR prod-
ucts were then digested with EcoRI and XmaI and frag-
ments were ligated into EcoRI-XmaI-digested pSAT4/
nVenus C1, yielding pSAT4/nVenus-TOM20, pSAT4/nVe-
nus-TOM22, pSAT4/nVenus-TOM40 and pSAT4/nVenus-
METAXIN. pSAT4/nVenus-TOM20mut was generated by
removing, via site-directed mutagenesis (primers Fp2274
and Rp2275), sequences encoding the first 142 amino
acid residues of TOM20 in pSAT4/nVenus-TOM20. This
N-terminal region of TOM20 contains a tetratricopeptide
motif-based receptor domain proposed to interact with
mitochondrial presequences [58].
To construct BiFC plasmids containing p36 fused at its C
terminus to nVenus, sequences encoding the entire p36
ORF was amplified via PCR using the appropriate oligo-
nucleotide primers (Additional file 4) and pRTL2/p36-
myc as template DNA. The PCR also introduced 5' EcoRI
and 3' XmaI sites. Resulting PCR products were then
digested with EcoRI and XmaI and fragments were ligated
into EcoRI-XmaI-digested pSAT4/nVenus C1, yielding
pSAT4/p36-nVenus.
pSAT4/mtOM64-nVenus, consisting of the Arabidopsis
mitochondrial outer membrane protein of 64-kD
(mtOM64), a protein proposed to function as mitochon-
drial protein receptor [60,52] and fused at its C terminusPage 19 of 26
(page number not for citation purposes)
BMC Cell Biology 2008, 9:54 http://www.biomedcentral.com/1471-2121/9/54to nVenus, was constructed in the following manner. Ini-
tially, a cDNA encoding mtOM64 was isolated using a
reverse-transcription PCR-based cloning procedure. Total
RNA was purified from (50 mL) of 4-day-old Arabidopsis
(Arabidopsis thaliana var. Landsberg erecta) suspension-cul-
tured cells using Tri Reagent (Sigma-Aldrich Ltd.) and
cDNA was then synthesized using an oligo(dT)18 primer
and the RevertAid™ H Minus First Strand cDNA Synthesis
Kit (Fermentas, Burlington, Canada). cDNA was then
used as a template in a PCR that included primers
(Fp2096 and Rp2097) designed specifically to amplify the
entire mtOM64 ORF along with 5' XhoI and 3' XmaI sites.
PCR conditions consisted of a 2 min incubation at 94°C,
followed by 35 cycles of 40 sec at 94°C, 40 sec at 55°C,
and 30 sec at 72°C, and then a 10-minute extension at
72°C. PCR products were ligated into pCR2.1 TOPO,
yielding pCR2.1 TOPO/mtOM64. Next, the XhoI-XmaI
fragments from pCR2.1 TOPO/mtOM64 was ligated into
XhoI-XmaI-digested pSAT4/nVenus C1, yielding pSAT4/
mtOM64-nVenus.
Construction of BiFC plasmids containing the βATPase
presequence, porin, p36, or p33 fused at their C termini to
cVenus was carried out as follows. Sequences encoding
either the βATPase mitochondrial targeting presequence
or the entire ORF of porin, p36 or p33 were amplified via
PCR using the appropriate oligonucleotide primers (Addi-
tional file 4). Plasmids used as template DNA in these
PCRs included pUC18/βATPase-GFP (see below 'Other
plasmids'), pUNI51/porin (ABRC, clone U12693) encod-
ing the Arabidopsis porin (also referred to as voltage-
dependent anion-selective channel protein 1), pRTL2/
p36-myc, and pRTL2/myc-p33 [25]. PCRs with plasmids
encoding porin, p36 and p33 also introduced a 5' EcoRI
site and a 3' XmaI site that removed each protein's stop
codon, whereas PCR with βATPase presequence-contain-
ing plasmid DNA introduced 5' and 3' BamHI sites.
Resulting PCR products were then digested with EcoRI and
XmaI or BamHI and fragments were ligated into EcoRI-
XmaI- or BamHI-digested pSAT4/cVenus N1, yielding
pSAT4/βATPase-cVenus, pSAT4/porin-cVenus, pSAT4/
p36-cVenus and pSAT4/p33-cVenus. To construct pSAT4/
cVenus-Cb5 consisting of the mitochondrial isoform (iso-
form D) of tung Cb5 [27] fused at its N terminus to cVe-
nus, the entire ORF of Cb5 along with 5' EcoRI and 3' XbaI
sites was amplified by PCR (primers Fp497 and Rp380)
from pRTL2/myc-ΔNheI Cb5D [27]. PCR products were
then digested with EcoRI and XbaI and ligated into EcoRI/
XbaI-digested pSAT4/cVenus C1, yielding pSAT4/cVenus-
Cb5.
Other Plasmids
pUC18/βATPase-GFP encoding the N-terminal mito-
chondrial matrix targeting presequence (residues 1–60) of
the β subunit of F1-ATPase from Nicotiana plumaginfolia
fused to the N terminus of GFP was constructed by ampli-
fying via PCR (primers FpRD1 and RpRD2) the βATPase
presequence along with 5' and 3' NheI sites, and using
pBIN35Sβ60catE9 (provided by F. Chaumont, University
of Louvain) [66] as the template DNA. The resulting PCR
products were then digested with NheI and ligated into
NheI-digested pUC18/NheI-GFP, a modified version of
pUC18/GFP [88] containing an in-frame NheI site imme-
diately upstream of the GFP ORF. The construction of
pRTL2/RFP, also referred to as pRTL2/MCS-RFP-stop, has
been described elsewhere [89]. pRTL2/RFP-MFP encoding
the RFP fused to the entire ORF of peroxisomal multifunc-
tional protein (MFP) was constructed by ligating the XbaI
fragment from pRTL2/GFP-MFP [90] into XbaI-digested
pRTL2-RFP-MCS [89].
Transient transformation of tobacco BY-2 cells and 
fluorescence microscopy
Tobacco (Nicotiana tabacum cv BY-2) suspension-cultured
cells were maintained and prepared for biolistic bombard-
ment as described previously [19]. Briefly, all transient
transformations, with the exception of those for BiFC (see
below), were performed using tungsten particles coated
with 10 μg of plasmid DNA (or 5 μg of each plasmid for
co-transformations) and a biolistic particle delivery sys-
tem-1000/HE (Bio-Rad Laboratories, Mississauga, Can-
ada). Bombarded cells were incubated for 4 h to allow for
expression and sorting of the introduced gene product(s),
then fixed in formaldehyde, incubated with 0.01% (w/v)
pectolyase Y-23 (Kyowa Chemical Products, Osaka,
Japan), and permeabilized with either 0.3% (v/v) triton X-
100 or 25 μg mL-1 digitonin (Sigma-Aldrich Ltd.) [26].
Cells were evaluated after 4 h to ensure that any potential
negative effects due to (membrane) protein over-expres-
sion were avoided.
Fixed and permeabilized cells were processed for immun-
ofluorescence microscopy as described by Trelease et al.
[91]. Primary and dye-conjugated secondary antibodies
and sources were as follows: mouse anti-myc antibodies
in hybridoma medium (clone 9E10; Princeton University,
Monoclonal Antibody Facility, Princeton, NJ, USA);
mouse anti-CAT antibodies in hybridoma medium (pro-
vided by S. Subramani, University of California, San
Diego); rabbit anti-cottonseed catalase IgGs [92]; mouse
anti-maize porin [24]; rabbit anti-pea E1β [93]; mouse
anti-α-tubulin (clone DM 1A) (Sigma-Aldrich Ltd.); rab-
bit anti-myc and mouse anti-HA (Bethyl Laboratories,
Montgomery, TX, USA); rabbit anti-p36 antibodies were
raised against a synthetic peptide corresponding to an
identical amino acid sequence in both p36 and TBSV p33
(-VEPARELKGKDGEDLLTGSR-) (residues 218–237 in
p36 and 184–203 in p33) (refer to the p33 and p36
sequence alignment shown in Figure 4A) [25]; goat anti-
mouse Alexa Fluor 488 IgGs (Cedar Lane Laboratories,Page 20 of 26
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(Jackson ImmunoResearch Laboratories, West Grove, PA,
USA). Concanavalin A conjugated to Alexa 594 (Molecu-
lar probes, Eugene, OR) was added to BY-2 cells at a final
concentration of 5 μg mL-1 during the final 20 min of
incubation with secondary antibodies. All antibodies
raised in rabbits were IgG-affinity purified using protein
A-Sepharose columns.
Epifluorescent images of BY-2 cells were acquired using a
Zeiss Axioskop 2 MOT epifluorescence microscope (Carl
Zeiss, Toronto, Canada) with a Zeiss 63× Plan Apochro-
mat oil-immersion objective. Image captures were per-
formed using a Retiga 1300 charge-coupled device camera
(Qimaging, Burnaby, Canada) and Northern Eclipse 5.0
(Empix Imaging, Mississauga, Canada) or OpenLab 5.0
(Improvision Inc., Lexington, MA, USA) software. CLSM
images of BY-2 cells were acquired using a Leica DM RBE
microscope with a Leica 63× Plan Apochromat oil-immer-
sion objective, a Leica TCS SP2 scanning head, and the
Leica TCS NT software package (Version 2.61) (Leica, Hei-
delberg, Germany). Fluorophore emissions were collected
sequentially in double- and triple-labeling experiments;
single-labeling experiments showed no detectable crosso-
ver at the settings used for data collection. Confocal
images were acquired as a z-series of representative cells
and single optical sections were saved as 512 × 512-pixel
digital images. All fluorescence images of cells shown in
individual figures are representative of > 50 independent
(transient) transformations from at least two independent
transformation experiments. Figure compositions were
generated using Adobe Photoshop CS (Adobe Systems,
San Jose, CA).
BiFC
Biolistic bombardment of cells for BiFC experiments was
carried out essentially as described above with the excep-
tion that tungsten particles were coated with 200 ng each
of plasmids encoding the appropriate combinations of
proteins. Tungsten particles were coated also with 200 ng
of pRTL2/RFP serving as an internal reference marker to
help identify cells that were transformed and, thus, could
be examined for the BiFC signal. Alternatively, particles
were coated also with 200 ng of pUC18/βATPase-GFP or
pRTL2/RFP-MFP serving as a mitochondrial or peroxiso-
mal marker protein, respectively, and for assessing (mito-
chondrial or peroxisomal) localization of co-expressed
Venus half fusion proteins.
Approximately 16 h after bombardment, cells were for-
maldehyde fixed and either examined (via fluorescence
microscopy) for BiFC (and RFP) or processed for immun-
ofluorescence microscopy as described above. The 16 h
time point and the amounts of plasmid DNA employed in
BiFC assays were chosen based on preliminary optimiza-
tion experiments aimed at eliminating the possibility of
any non-specific (false positive) reconstitutions that may
occur due to protein (over)expression [reviewed in
[94,95]]. Overall, the conditions used for BiFC were based
on those in which nVenus- or nVenus-tagged versions of
the various TOM proteins, p36, p33, porin and the βAT-
Pase presequence co-expressed with the corresponding
"empty" vector containing the nVenus or cVenus alone
yield no significant BiFC (Venus) fluorescence (data not
shown). Also, transformations with RFP (or βATPase-GFP
or RFP-MFP) alone, confirmed that there was no cross-
bleed of the red (or green) fluorescence signal into the yel-
low channel.
Topological orientations of Venus half fusion proteins
were determined using digitonin (differential) permeabi-
lization as described above, with the exception that biol-
istic bombardments were performed with gold particles
(Sigma-Aldrich Ltd.) coated with 5 μg of plasmid DNA,
and cells were formaldehyde fixed ~4 h after bombard-
ment.
Rub inoculation of C. quinoa and electron microscopy
Chenopodium quinoa plants were grown in chambers at
21°C with a 12 h light-12 h dark cycle and five days prior
to rub inoculation plants were transferred to a laboratory
bench top with lower light conditions to facilitate the
infection process [86]. Rub inoculations (including mock
inoculations) were carried out with 6-to-8-leaf stage
plants and 10 μg of CIRV infectious cDNA diluted in 30 μl
of inoculation buffer [86]. Approximately 7 to 10 days
after inoculations, ~1 cm2 sections of the rub-innoculated
leaf, including several necrotic lesions, were removed and
processed for electron microscopy.
CIRV cDNA rub-inoculated C. quinoa leaf pieces were
processed for transmission electron microscopy (TEM) by
fixing in 4% (v/v) gluteraldehyde (Fisher Scientific,
Markam, Canada) and 1% (v/v) acrolein (Sigma-Aldrich
Ltd.) in 0.025 M NaKPO4 buffer (pH 7.2) for 2 h in a vac-
uum chamber and then at 4°C overnight. Samples were
then washed three times in 0.025 M NaKPO4 buffer at 2 h
intervals and 4°C, then post-fixed overnight at 4°C in 1%
(w/v) osmium tetroxide (Fisher Scientific), dehydrated in
a graded series of ethanol (50 to 100% [v/v]), and embed-
ded in Spurr's medium-grade epoxy [96]. Thin sections
were cut with a glass or diamond knife, mounted on cop-
per grids and post-stained with 2% (w/v) uranyl acetate
and Reynold's lead citrate [97] for 10 and 3 min, respec-
tively. All images were acquired at 80 kV with a Phillips
(Mahwah, NJ, USA) CM10 TEM.
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as follows: βATPase (P17614), Cb5D (AAT84461), CIRV
p36 (CAA59477), CIRV p95 (NP_612580), METAXIN
(NP_565446, At2g19080), MFP (AAL35606), mtOM64
(NP_196504; At5g09420), porin (Q9SRH5; At3g01280),
TBSV p33 (NP_062898), TOM20 (NP_189344;
At3g27080), TOM22 (NP_563699; At1g04070), TOM40
(NP_188634; At3g2000).
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Additional material
Additional file 1
Localization of p36 expressed alone or together with the p95 replica-
tion protein in BY-2 cells and electron microscopic analysis of 
Chenopodium quinoa meosphyll cells transformed with CIRV. (A) 
Tobacco BY-2 cells were transformed transiently (via biolistic bombard-
ment) with p36 either alone, together with the other CIRV replication pro-
tein p95 (Rep), or in the context of full-length infectious CIRV (CIRV 
cDNA). Cells were then processed for immunofluorescence CLSM with 
expressed p36 and p95 being immunodetected using primary antibodies 
raised against a synthetic peptide that corresponds to an amino acid 
sequence in both p36 and p95 [25]. As mentioned in the 'Introduction', 
p95 is produced by the translational read-through of the p36 amber stop 
codon [7]. Hatched boxes represent the portion of the cells shown at 
higher magnification in the panels to the right. The yellow/orange color in 
the merge images indicate co-localization of expressed p36 (and p95) and 
the endogenous outer mitochondrial membrane protein porin; arrowheads 
also indicate obvious co-localizations. Bar = 10 μm. (B) Individual C. 
quinoa leaves rub-inoculated with an infectious CIRV cDNA (see 'Meth-
ods and Materials' for details) or mock rub-inoculated at 7 days post inoc-
ulation. Arrowheads indicate examples of necrotic lesions on the surface 
of the CIRV-infected leaf; necrotic lesions were not observed on leaves of 
mock rub-inoculated plants. Bar = 2 cm. (C) Representative transmission 
electron micrographs of a mitochondria-derived MVB and wild-type mito-
chondrion in mesophyll cells of C. quinoa leaves rub-inoculated with the 
infectious cDNA of CIRV and mock rub-inoculated, respectively. Arrow-
heads denote examples of distinct vesicle/spherule-like structures located 
in the intermembrane space of the mitochondria-derived MVB that are 
proposed to be derived by invaginations of the outer mitochondrial mem-
brane and serve as the sites for CIRV RNA replication [13,4]. Note also 
that the cristae are significantly altered (and less in number) in the mito-
chondria-derived MVB of the CIRV-transformed cell; compare with mor-
phology of the cristae in the mitochondria of the mock-transformed cell. 
CW, cell wall; Cyt, cytosol; Mito, mitochondria; mMVB, mitochondria-
derived multivesicular body; Vac, vacuole. Bars = 0.5 μm.
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Additional file 2
Localization of p36-CAT and topological orientation of p36 90-190-
CAT in BY-2 cells. (A) Tobacco BY-2 cells were transformed transiently 
(via biolistic bombardment) with p36 90-190-CAT (consisting of the p36 
amino acid residues 90–190 fused to the N-terminus of CAT) and then 
processed for immunofluorescence CLSM using primary antibodies raised 
against CAT. Hatched boxes represent the portion of the cells shown at 
higher magnification in the panels to the right. The merged image shows 
that the torus fluorescent structures containing p36 90-190-CAT deline-
ate the spherical structures attributable to mitochondrial matrix-localized 
E1β. Arrowheads indicate obvious examples of a toroidal enclosure of a 
sphere. Bar = 10 μm. (B) BY-2 cells were transformed transiently (via 
biolistic bombardment) with p36 90-190-CAT, fixed, and then permea-
bilized with either triton X-100 (which permeabilizes both the plasma 
membrane and organellar membranes) or digitonin (which permeabilizes 
only the plasma membrane). Permeabilized cells were then processed for 
(immuno)epifluorescence microscopy using antibodies raised against (as 
indicated by the labelling at the top left of each micrograph) either 
cytosolic α-tubulin, mitochondrial matrix E1β, or CAT (in p36 90-190-
CAT). Note that, similar to endogenous cytosolic α-tubulin, p36 90-190-
CAT, but not endogenous mitochondrial matrix E1β, were immunode-
tected in both triton X-100- and digititon-permeabilized cells, indicating 
that the C-terminal-appended CAT moiety was exposed to the cytosol. 
Although the relative position of the N terminus of p36 90-190-CAT was 
not directly tested in these differential permeabilization experiments, this 
fusion protein, similar to full-length p36 (refer to Figure 2), is likely ori-
entated in an Nout-Cout topology. This is because the cytosolic-facing C ter-
minus of p36 90-190-CAT, together with an even number (two) of 
predicted TMDs, suggests that its N terminus is also exposed to the cytosol. 
Differential interference contrast (DIC) images correspond to the same 
cells shown to the left. Bar = 10 μm.




Localization and topology of nVenus and cVenus fusion proteins used 
in BiFC assays. (A) Tobacco BY-2 cells were transformed transiently (via 
biolistic bombardment) with selected individual nVenus (and myc-
tagged) or cVenus (and HA-tagged) fusion proteins as shown in Figures 
7A and 7B (refer to Methods 'Construction of plasmids: Plasmids 
used for BiFC' for details on the cloning of individual Venus half and 
epitope-tagged fusion proteins). With the exception of cell transformed 
with p33-cVenus, all cells were also co-transformed with βATPase-GFP, 
consisting of the N-terminal mitochondrial targeting presequence (resi-
dues 1–60) of the βATPase fused to the N terminus of GFP, and serving 
as a well-established mitochondrial marker protein [66,67], and thus 
confirming their mitochondrial localization. Cells transformed with p33-
cVenus were co-transformed with RFP-MFP, consisting of the RFP fused 
to the N-terminal end of peroxisomal matrix marker protein MFP serving 
as a peroxisomal matrix marker protein [90,99]. At ~16 h post-bombard-
ment, all cells were then processed for (immuno)epifluorescence micros-
copy using anti-myc or anti-HA antibodies. Each micrograph is labelled at 
the top left with the name of the transiently co-expressed fusion protein. 
Differential interference contrast (DIC) images correspond to the same 
cells shown to the left. Note that with the exception of peroxisomal-local-
ized p33-cVenus, all individual nVenus and cVenus fusion proteins sorted 
to mitochondria as evidenced by their co-localization with βATPase-GFP. 
p33-cVenus, on the other hand, colocalized with RFP-MFP, as expected 
for this peroxisomal-localized viral protein [25]. Bar = 10 μm. (B) BY-2 
cells were transformed with various individual nVenus (and myc-tagged) 
or cVenus (and HA-tagged) fusion proteins as in (A); however, cells were 
incubated with digitonin (rather than triton X-100 as in [A]) which per-
meabilizes only the plasma membrane and not organellar membranes 
[26]. Permeabilized cells were then processed for immuno(epi)fluores-
cence microscopy using anti-myc, anti-HA, anti-E1β, anti-βATPase and/
or anti-α-tubulin antibodies. Each micrograph is labelled at the top left 
with the name of the transiently-expressed fusion protein or endogenous 
E1β, βATPase or α-tubulin. Note that the presence or absence of an 
immunofluorescence signal attributable to an expressed fusion protein 
indicates whether or not the protein's appended myc- or HA-epitope tag 
(immediately adjacent to nVenus or cVenus, respectively) is exposed to the 
cytosol or not; compare to the absence or presence of an immunofluores-
cence signal attributable to mitochondrial matrix-localized E1β or 
cytosolic α-tubulin in the same cells. Note also that the relative position of 
the myc- or HA-epitope tag (and the immediately adjacent nVenus or cVe-
nus fragment, respectively) for selected fusion proteins localized to the 
mitochondrial outer membrane are shown in Figure 7B (indicated with 
asterisks). DIC images correspond to the same cells shown to the left. Bar 
= 10 μm.




List of synthetic oligonucleotide primers used in the construction of plas-
mids.
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